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ABSTRACT
The American University in Cairo
“Prevalence and Determinants of Self-Medication with Antibiotics in high & lowincome areas within Cairo”
Student Name: Shaymaa M. Hassan
Supervisors: Dr. Rania Siam & Dr. Mahmoud Shaltout

Antimicrobial Resistance (AMR) is currently a global threat, and one of the reasons for
increasing AMR rates is antibiotics overuse. Antibiotics overuse is not only due to
physician prescriptions -although that is also high- but also because of self-medication with
antibiotics (SMA). SMA varies across countries and populations depending on multiple
factors and among them is the socioeconomic status. Socioeconomic disparities have been
linked to SMA rates. In Egypt, namely Cairo, little data is available regarding SMA or
surveillance of antibiotic consumption. The aims of this study were to a) estimate and
compare the prevalence of SMA in two socioeconomically different areas in Cairo (high
and low-income) b) identify determinants associated with SMA and c) Identify the types
of antibiotics used the most. Results showed that SMA was four times more prevalent in
low-income area compared to the high-income area (p = 0.00). However, total consumption
of antibiotics per family, whether by SMA or prescription, was significantly higher (p =
0.037) in the high-income area. Amoxiciillin was found to be the most consumed antibiotic
in both areas Maadi (60.7%) and Shagret Mariam 48.2%. The main reason for SMA in
both areas was having previous experience with similar symptoms. Other reasons differed
between low income areas (cost of physician) and higher income areas (saving time).
Income and education were among the factors related to SMA whereas with lower
education and low-income area, there was higher rates of SMA. Further research is
recommended to understand SMA behavior and its’ socioeconomic determinants, in order
to address interventions for regulating antibiotic use.
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Literature Review & Introduction
1.1 Global Health Threat and Worldwide Prevalence
An antibiotic is defined as “any class of organic molecule that inhibits or kills microbes
by specific interactions with bacterial targets, without any consideration of the source of
the particular compound or class” (Davies, 2010). Antibiotics transformed the medical
world and saved thousands of lives since their discovery few decades ago (Davies, 2010
& Gould & Bal, 2013).The high rate of antibiotic usage is speeding up the emergence of
resistant genes in infectious microbes (Lobanovska & Pilla, 2017). Antibiotic resistant
genes are genes that develop the ability to resist and withstand the effect of antibiotics
without getting affected (van Hoek et al., 2011) and the mechanism is either by
enzymatically inhibiting antibiotics or through other mechanisms (Davies & Davies,
2010). The resistant genes are not new; they have been always around and part of the
natural cycle of microbial evolution and adaptability (Spellberg et al., 2008). Microbes
develop resistant genes either intrinsically through random mutation or by a selective
pressure through the spread of a genetic material (resistant genes) from one bacteria to
another (Fletcher, 2015). The problem is the overuse of antibiotics in medical settings
(many times as prophylactic) in agricultural, wastewater effluent, and livestock as
preventive medicine to have greater improvement in production and lower cost with less
and less infections (Suzuki & Hoa, 2012). The spread of antibiotics use in the
environment is causing selective pressure for resistant genes to emerge, contrary to
intrinsic resistance, which is believed to be far less common in causing the emerging of
resistant genes (Tello et al., 2012). Antibiotic / Antimicrobial Resistance (AMR) is the
ability of microbes (bacteria, fungi, viruses, and parasites) to resist the effects of drugs –
that is, the germs are not killed, and their growth is not stopped, so the drug is not
effective anymore causing difficulty to control spread of infections (Centers for Disease
Control and Prevention, 2017). Microorganisms that develop AMR are sometimes
referred to as “superbugs” (World Health Organization, 2016). “Antibiotics and similar
drugs together are called antimicrobial agents - have been used for the last 70 years to
treat patients who have infectious diseases” (CDC, 2017). AMR is becoming a global
9

rising health threat in all parts of the world, especially in developing countries, which
affects the ability of current medicine to treat common infectious diseases such as
pneumonia, tuberculosis, blood poisoning and gonorrhea (Roca et al., 2015) & (WHO,
2016). AMR in the European Union EU, Iceland and Norway is high and increasing
causing serious human and economic consequences according to the European Center for
Disease Control ECDC (2009) & (Miller-Petrie & Gelband, 2017). Diseases that seemed
treatable are becoming difficult to cure, and one of the main driving reasons for AMR is
the overuse of antibiotics in high and Low and Middle Income Countries (LMICs)
(Gelband et al., 2015). Data from developing countries are not as available as from the
EU, and is expected to be even higher due to the higher rates of infections resulting from
poor environmental and health service (Molly Miller-Petrie & Gelband, 2017). According
to the World Bank, there is a lack of clinical laboratories availability in LMICs such as in
East Africa, where research indicates that the challenge of data collection comes from not
only proper surveillance systems but also lack of technical capabilities that provide
microbial testing (Aboderin & Martinez, 2016).

Multidrug resistance (MDR) is defined as "the insensitivity or resistance of a
microorganism(such as bacteria, viruses, fungi and parasites) to the administered
antimicrobial drugs (like antibiotics, antivirals, anti-fungal and anti-parasitic) despite
earlier sensitivity to it which makes the conventional therapy ineffective leading to more
spread of infection (Singh, 2013). In February of 2017, the WHO published a priority list
of pathogens with the greatest threat to the human public health, divided into critical, high,
and medium threats (WHO, 2017). One of the critically threatening pathogens is
carbapenem-resistant Enterobacteriaceae such as Klebsiella species and Escherichia coli
(E. coli) and those bacteria are becoming more and more resistant to the strongest available
antibiotics (Lutgring & Limbago, 2016 & CDC, 2013). Carbapenems is a potent broad
spectrum class of antibiotics used to treat multi drug resistance pathogens however recently
carbapenem-resistant Enterobacteriaceae such as Klebsiella species are increasing
resistant through different mechanisms (ESER, 2017). One of those is production of
carbapenemze enzymes to inactivate antibiotics or through intrinsic bacterial mechanism
10

such as forming biofilms as protection layers (Vuotto et al., 2014). Other examples of
MDR

microbes

include;

methicillin-resistant

Staphylococcus

aureus

(MRSA),

Streptococcus pneumoniae and Mycobacterium tuberculosis (Fair & Tor, 2014) (Spellberg
et al., 2008). MRSA is a serious health threat that causes skin, pneumonia, and bloodstream
infections and more resistant than Staphylococcus aureus (Durai et al., 2010). In 2005,
around 94,000 estimated cases of MRSA infections in the Unites States required
hospitalization and around 19,000 death cases resulted from the same infection with 85%
of all the infections happening in healthcare settings like hospitals and clinics (Klevens et
al., 2007). However, some reports described a decline in the rate of infections in the United
States due to improved infection prevention and control, but there is a discrepancy because
data is different from one population to the other (Kavanagh et al., 2017). Europe also
witnessed a decline in hospital acquired MRSA by 2% from 2012 to 2015, however there
is an increase in the community acquired MRS (EARS-Net, 2017). Streptococcus
pneumoniae is a type of bacteria that can cause wide range of respiratory tract infections
such as pneumonia and meningitis and bloodstream infections (Adegbola et al., 2014).
Resistance of Streptococcus pneumoniae started to appear gradually since the 1970s and
currently there is the MDR Streptococcus pneumoniae which usually is resistant to more
than 3 types of antibiotics (Cornick and Bentley, 2012). Mycobacterium Tuberculosis
which is an airborne infectious disease that causes tuberculosis disease TB is becoming
also increasingly resistant. Multidrug-resistant tuberculosis MDR-TB is the TB bacterium
that is resistant to at least isoniazid and rifampin, which are the two most potent current TB
drugs (Pai et al., 2016).

In high-income countries, there is a high rate of antibiotic usage in hospitals,
communities, and agricultural sectors, which are adding selective pressure on microbes
to develop resistance (Hughes, 2014). The overuse of antibiotics in medical settings
adds a pressure on the microbe to develop resistance over time and become then
susceptible to antibiotics (Shallcross & Davies, 2014). In Europe, there is an increase in
resistant strain isolates of bacteria showing amitotic resistance or multiple drug
resistance (EARS-Net, 2017). There are around 1000 resistance-related beta-lactamases
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(antibiotic-inactivating enzymes) bacteria that are resistant to beta-lactam class of
antibiotics have been identified till now and this class of antibiotics in considered a
strong last-option treatment (Laxminarayan et al., 2013) which is a significant number
of bacterial species that developed resistance mechanism for only one class of
antibiotics. In Europe, about 25,000 patients die annually from infections caused by
MDR bacteria (ECDC, 2009). The most common infections in France that caused
around 158,000 cases of MDR infections in 2012 were MRSA, Escherichia
coli and Klebsiella pneumoniae (Colomb-Cotinat et al., 2016). In the United States,
around 23,000 people die from antibiotic-resistant bacteria and at least 2 million people
get serious infections with one or more of the resistant bacteria and these infections
usually require hospitalization (CDC, 2013). One example of one type of enteric
pathogens is Clostridium difficile which infects around 250,000 people annually in the
USA and requires hospitalization in addition to 14,000 death cases annually (CDC,
2013).

In LMICs little data is available on AMR and MDR infections because of the
lack of control of antibiotic dispersion, regulations and surveillance (Dondorp et al.,
2017). For example, in Thailand as a country representing one of the LIMC country,
there are around 45,209 acquired MDR infections (both hospital and communityacquired) and of them around 19,122 deaths per year from the 66 million population of
Thailand in 2010 (Lim et al., 2016). The number of deaths in Thailand is similar to
Europe however, the population of whole countries in Europe is much greater than in
Thailand which reflects the relative percentage of MDR infections. In India, one of the
most populated developing countries with many health and economic challenges, more
than 5 million children under the age of 5 year old get infected with pneumonia or sepsis
(Caused by Streptococcus pneumoniae and Haemophilus influenzae type b respectively)
and 215,000 children die out of the 5 million (Ganguly, 2011). In Nepal, MDR E.coli
isolates were found highly prevalent in hospital settings for multiple antibiotics (Ansari
et al., 2015). A 6-year surveillance study in 503 intensive care unit ICUs in LMICs in
Latin America, Africa and Asia in which they are all part of the International
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Nosocomial Infection Control Consortium (INICC), the data collected from 605,310
patients showed that device-associated infections were higher by around 5 folds in these
countries in comparison to the rate in the ICUs in the US where similar device utilization
in hospitals is happening (Rosenthal et al., 2014). In Middle East countries, there is
variation in economic prosperity, yet most of them lack basic laboratory settings for
antibiotic susceptibly testing and surveillance control leading to an under-reporting of
MDR infections (Ahmed et al., 2016).

According to pharmaceutical sales, consumption of antibiotics is rising globally,
and one example is Carbapenem (Group of antibiotics used to treat MDR bacteria and
more expensive than the other antibiotics) which has dramatically increased sales in
LMICs such as India, Pakistan and Egypt (Laxminarayan et al., 2013). The World
Health Organization WHO is tackling the issue of AMR with high priority, and a plan
was endorsed in May 2015 World Health Assembly and recently in the United Nations
General Assembly in New York in September 2016, the Heads of State committed to
taking a broad, coordinated approach to address the root causes of AMR across multiple
sectors (WHO, 2016).

1.2 Prevalence of Antimicrobial Resistance in the Middle East
Antibiotics are prescribed over the counter in many LMICs including the Middle East,
where there are higher rates of infections due to poor environmental and health services
(Miller-Petrie & Gelband, 2017). AMR is a problem in the Gulf countries (Qatar, Bahrain,
Saudi Arabia, Oman and UAE) with the most prevalent organisms being Escherichia
coli, followed by Klebsiella pneumoniae and other pathogens (Balkhy et al., 2016). AMR’s
prevalence in the Gulf countries is mainly due to availability of the most advanced
antibiotics and lack of infectious control systems (Aly & Balkhy, 2012). Shibl et al., (2009)
showed that resistant Streptococcus pneumoniae infection, in the Arabian Peninsula and
Egypt has a high resistance to penicillin which has been increasing over the years from 0%
in the 1980s to 20-40% in the late 1990s and reached 50-80% in 2005. In Qatar,
cephalosporin resistance against Streptococcus pneumoniae has been reported to be 12%
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in children under 12 years old (Al-Tawfiq et al., 2010). Regarding enteric bacteria, in
Oman, 31% of the community Escherichia coli (E.coli) (found in outpatients not
hospitalized ones) found in urinary tract isolates were resistant to the antibiotic
ciprofloxacin which is usually prescribed to treat such infections (Al-Lawati et al., 2000).
Similar types of community E.coli isolates in Lebanon were 25% resistant to ciprofloxacin
however isolates from inpatients (hospitalized ones) showed much more resistance which
is around 40-46% (Fadel et al., 2004). In Saudi Arabia, it was 19% resistance found in the
outpatients and 49% in the inpatient (Al-Tawfiq, 2006). In Turkey, comparable isolates
from the community (outpatients) showed the highest rates of resistance that is 42.1%
which are similar to inpatient resistance rates in other countries (Yilmaz et al., 2009).

1.3 SMA in the Middle East
Antibiotics consumption without prescription is very common in the Middle East and the
misuse by many patients is believed to be highly prevalent (Al-Tawfiq et al., 2010) &
(Khalifeh et al., 2017). Over the counter medicines in general are being widely used in the
Eastern Mediterranean countries (pain killers and antibiotics) without prescription, and
behaviors of self-medication were also observed in different studies (Khalifeh et al., 2017).
Many people in the Middle East believe that antibiotics should be taken to treat fever which
is often caused by a viral infection, and antibiotics is the first treatment option people turn
to (Aly & Balkhy, 2012). A cross-sectional study in Palestine supporting Aly & Balkhy
(2012), showed that 73% of parents choose antibiotics as the treatment for Upper
Respiratory Tract Infections (URTIs) for their children and 59% of the parents did not
agree that URTIs are mostly caused by a virus (Zyoud et al., 2015). The more serious
misuse of antibiotics is taking antibiotics as prophylactic medicine especially pre and postoperative which has been observed in different studies (Al-Tawfiq et al., 2010). The
overuse of antibiotics in hospitals and community is one of the factors contributing to AMR
(Prestinaci et al., 2015). A In Beirut, 32% of antibiotics were dispensed without medical
prescription and that was more common in lower-income areas than higher (Farah et al.,
2015).

Furthermore, a larger scale retrospective study from Lebanon also, showed

significant AMR challenges where data from 16 Lebanese hospitals were analyzed and
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showed that the prevalence of MRSA in hospitals is 27.6% and Streptococcus pneumoniae
had different susceptibilities depending on the antibiotics used where it ranged from 46%
to oxacillin, 63% to erythromycin, and reached even 98% to levofloxacin (Chamoun et al.,
2016). A surveillance using nasal swabs for healthcare workers and community members
in Sudan showed that 20% had Streptococcus aureus and 80% of these isolates were
MRSA which was more frequent in the healthcare workers (Babiker et al., 2017). In
Kuwait, isolates from a five year data collection of Clostridium difficile infection (which
causes diarrhea) have been collected and tested to assess resistance and showed high
resistance against different antibiotics including ampicillin, clindamycin, and levofloxacin
(Jamal & Rotimi, 2016). Also in Kuwait, another study of the community-acquired MRSA
has shown an increase in a five year study (2011-2015) however the susceptibility to
antibiotics varied along the years which indicates the importance of regular surveillance
(Udo et al., 2017). A two year cohort study in Kuwait, United Arab Emirates and Saudi
Arabia showed that the main cause for neonatal sepsis infections are Coagulase-negative
staphylococci and Klebsiella which were resistant to third-generation antibiotics
Cephalosporins (Hammoud et al., 2017). In Algeria, a study showed high prevalence of
MDR Klebsiella pneumoniae isolates on surfaces at 3 teaching hospitals which were
producing b-lactamases enzymes that are resistant to beta-lactam antibiotics (Zenati et al.,
2017). An analysis of all published research on AMR in Africa indicated that around 40%
of all countries in the continent did not have any data on AMR which presents a gap in
proper surveillance and understanding the magnitude of the problem (Tadesse et al., 2017).

1.4 AMR in Egypt
Consumption of antibiotics in Egypt is high in both healthcare settings and within the
community as shown by a survey conducted in 18 hospitals in Egypt (Talaat et al., 2014).
This study showed high prevalence of antibiotic use in which 2017 treated patients had
received a total of 3194 antibiotic drugs (which means 1.6 antibiotics per patient). AMR
as a consequence for over-consumption of antibiotics is increasingly appearing in
healthcare settings in Egypt whereas a 10-month active surveillance in three hospitals
indicated around 600 pathogens isolated from blood cultures of 1,575 patients where 79%
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of all Klebsiella pneumoniae isolates were β-lactamase-producing and MRSA was present
in 60% of all Staphylococcus aureus isolates (Saied et al., 2011). Moreover, in a period of
three months from October to December 2016, a surveillance of 28 hospitals showed that
in this short time, 91 intensive care units (ICU) resulted in 2688 cases of health-care
associated infections with Klebsiella spp and Acinetobacter spp as the two most common
infectious pathogens in hospitals in Egypt (Talaat et al., 2016) and Out of the Klebsiella
spp infections, 92.8% were MDR species. Analyzing the prevalence of resistance of
healthcare- and community-associated MRSA in Egypt over a period of 8 years (2005–
2013), 631 Staphylococcus aureus isolates were found and 88% of them were MRSA
which was more abundant in the healthcare setting (76.6 %) (Abdel-Maksoud et al., 2016).
Around 68% out of 100 patients with gastrointestinal complaints in Zagazig, Egypt, had
Extended spectrum β-lactamases Enterobacteriaceae which are resistant to beta-lactam
antibiotics and the isolates were mainly E. coli and Klebsiella pneumoniae (Abdallah et al.,
2017). The Egyptian ministry of Health put together a strategy for AMR for between 2016
to 2020 to control and regularly provide national surveillance (Wagdy, 2016). The strategy
is divided into three programs; first to monitor the Hospital Acquired infection (HAI) and
the second is the detection of community acquired infection and the third is surveillance
for the veterinary and environmental sectors however there is no much details on the scale
of the surveillance (Wagdy, 2016).

1.5 Causes of AMR Worldwide and in Middle East
1.5.1 Over-use of antibiotics
The overuse of antibiotics is the main driving force causing antibiotic resistance whether
through human consumption or in commercial agriculture and livestock (Laxminarayan et
al., 2013). Antibiotic overuse also causes higher risk of side effects to patients, reinfection
and re-admission to hospitals (Llor & Bjerrum, 2014). Bacterial mutation rate is very high
and bacteria developed different mechanisms for increasing resistance to antibiotics such
as the biofilm structure of bacteria and with high human consumption of antibiotics,
bacteria develops resistance relatively very fast (Reardon, 2014). Around 50% of all
antibiotics prescribed are not really needed or used effectively to treat infections (CDC,
16

2013) and the more antibiotics are used, the more opportunities the bacteria get to evolve
and develop resistance. Between 2000 and 2010, antibiotics consumption was increased by
35% in around 71 countries worldwide (Van Boeckel et al., 2014). Such a huge amount of
antibiotics dispensed into human bodies and the environment creates niches for infectious
pathogens to evolve and resistant genes to develop. Most of the serious resistant bacterial
infections come from health-care settings where MDR infections are widespread and hard
to treat (Health Policy Brief, 2015). In addition to the overuse of antibiotics, sometime
patients do not adhere to finishing the course of antibiotics prescribed for them and this is
a great risk for AMR and for reinfection to take place (Fernandes et al., 2014). This nonadherence theory is supported by research that indicated that low non-lethal concentrations
of antibiotics cause high risk for mutations and even further increasing stability of mutants
genes (Andersson & Hughes, 2012).

Overuse of antibiotics is not limited to medical settings, but also in other areas such
as livestock and agriculture which consume great amounts of antibiotics worldwide (Levy,
2014). Farming companies/farmers are using antibiotics on prolonged periods for
promoting growth and preventing illnesses which eventually makes it the ideal
environment for appearance of resistant genes (Levy, 2014). The overuse in the
environment spreads out resistant genes and causes high risk for transmission to humans
and it has been shown that these evolved resistant genes are found in the stomach of human
consuming or in close interaction with livestock (Chang et al., 2015). More recent evidence
showed that resistance genes are being transferred from animals to humans based on whole
genome sequencing (Harrison et al., 2013). In the United States, human consumption of
antibiotics represents only around 20% and the rest is used in agriculture, fish farming and
livestock (Health Policy Brief, 2015). In Europe, the use of livestock is not as high as in
the USA and some countries are restricting now the use of antibiotics in livestocks.
Denmark is one of the few countries taking the lead successfully in limiting antibiotic use
in livestock and agriculture (Levy, 2014). Recently, interesting findings revealed that
disposed wastewater from hospitals actually are a niche for the emergence of antimicrobialresistant genes since a lot of antibiotics used in the hospitals (Czekalski, et al., 2014).
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1.5.2 Decline in development & research of new antibiotics
Between the 1940 and 1962, 20 new antibiotics were introduced which revolutionized
human medicine and saved millions of lives and the use of antibiotics extended beyond
the medical field (Coates et al., 2011). Since then most of the newly marketed antibiotics
are just analogues of the already discovered ones from the late 1960s and few ones have
been developed since (Coates et al., 2011). Antibiotics research and development does
not attract pharmaceutical industry for multiple factors, one of them is their short time
treatment duration (usually less than two weeks) for total cure. The second reason is that
other drugs taken for chronic diseases are usually given for longer duration and
accordingly they are more profitable and regularly on demand since patients get these
medications over the course of their life time (Spellberg et al., 2007). In addition, it is
more affordable to fund research and development of analogues of antibiotics than to
develop new compounds of antibiotics (Coates et al., 2011).

1.5.3 Self-medication with Antibiotics SMA (Worldwide & Middle East)
SMA is one of the causes accelerating the AMR problem globally which has serious
consequences (Versporten et al., 2014). Numerous studies have been conducted in
developed countries to detect the scale of the problem on different population groups,
however fewer studies have been carried out in developing countries where the problem is
more widespread, and surveillance is not regular or sometimes absent (Okeke et al., 2005).
In Europe however, there are more data available that compares different countries’
prevalence. There is a significant variation within the European countries whereas, the
highest rate of SMA was in France and the lowest rate was in the Netherlands (Goossens
et al., 2005). In the United States, antibiotics are being sold without prescription online a
lot with the most available antibiotics penicillin which is available by 94.2% of all the
online outlets which encourages SMA greatly (Arch et al., 2009).

Some countries in the Middle East studied SMA behaviors and determinants, but
not on a large enough scale to understand the complex issue in relation to AMR. However,
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these available publications together show the need for more research on SMA. Sudan and
Jordan had the highest SMA rates followed by Abu Dhabi and Beirut. In Sudan, 73.9% of
the studied population (which was around 1293) had used antibiotics or antimalarial
without a prescription within one month prior to the study (Awad et al., 2005). In Jordan,
67.1% of patients believe that antibiotics treat common cold and cough, 28.1% misused
antibiotics as pain killers, 11.9% of females were not aware of antibiotic safety and usage
during pregnancy, 28.5% had antibiotics at home for emergency and 55.6% used them as
preventive treatment against potential infections (Shehadeh et al., 2012). In Abu Dhabi,
56% (out of 860) reported the use of antibiotics during the last year and 46% stated that
they intentionally use antibiotics as self-medication with no physicians’ prescription and
the research indicated that the higher level of education, the higher rate of self-medication
(Abasaeed et al., 2009). However, the percentage is less in Beirut, where 42% of people
purchasing antibiotics are getting them without prescription and 39.7% of them said that
the main reason they did not go to a physician was to save time (Mouhieddine et al., 2015).
In Kuwait, a similar research was carried out and around 72.8% of participants had taken
antibiotics in the last year before the study and 27.5% of them had antibiotics without
medical prescription (A. I. Awad & Aboud, 2015). Regarding adherence and finishing the
course of treatment, in Kuwait 36% of antibiotic consumers did not adhere to the course of
treatment (A. I. Awad & Aboud, 2015). In Riyadh in Saudi Arabia, 78% of pharmacies
dispense antibiotics without prescription (Habibzadeh, 2013). Another study in Saudi
Arabia indicated that (70.5%) of the pharmacists in Makkah were not aware that dispensing
antibiotics without prescription was illegal (Hadi et al., 2016). Another factor contributing
to AMR is non-adherence to the course of antibiotics which promotes recurrence of
infections, resistant of bacteria and the inability to treat the initial infection (Fernandes et
al., 2014). Ocan et al., 2015 indicated that SMA prevalence is high in many different
countries and this variance is associated with social determinants of health such as
education and socioeconomic level.
1.6 Self-medication with Antibiotics in Egypt
In Alexandria, Sallam et al., 2009 found that 79.9% of the pharmacy visitors reported SMA
and the main reason was that patients (pharmacy visitors) perceived their health problem
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as a minor issue (44.5% thought so) or that they had previous experience from past
prescription (Sallam et al., 2009). Another research in Alexandria indicated that 66.9% of
pharmacists reported an increase in non-prescribed dispensing of medicines in the last 4
years from 2009 to 2012 (Elhoseeny et al., 2013). In Minya, assessment of physicians and
pharmacists prescribing antibiotics for Acute Respiratory Infections (ARI) and the factors
behind prescriptions revealed a majority of physicians (64%) and pharmacists (81%)
prescribed antibiotic for common cold (Dooling et al., 2014). These results show that there
is overprescribing for antibiotics when it is really not needed, and also there is under
prescription for infectious diseases like pneumonia that needs antibiotics. These results
highlight the necessity and need for awareness of physicians and pharmacists themselves
about the safety and use of antibiotics. Hospitals, where MDR infections are more serious,
are another area that needs more investigation.

One study in Cairo, conducted over a three-month period of months showed that
1158 antibiotics were dispensed for 884 patients and 23.3% of these antibiotics were
dispensed without prescription or pharmacist recommendation (Sabry et al., 2014).
Remarkably, the antibiotics that were dispensed on pharmacist recommendations were
dispensed by technicians (Sabry et al., 2014). Interestingly, respiratory tract infections were
among the leading symptoms/conditions for consuming antibiotics which are viral
infections mostly (Sabry et al., 2014). Another cross-sectional study was conducted on 300
medical students from Ain Shams University, and prevalence of SMA among these
students was 55% (El Ezz & Ez-Elarab, 2011). More than half of the participating medical
students (63.3%) discontinued the self-medication once feeling improvement compared to
14.4% who properly continued the correct course of prescription. Also 60% of students
increased the dose of the drug without medical advice (El Ezz & Ez-Elarab, 2011). This
prevalence of SMA is high among medical students, and it is critical that they understand
and follow the guidelines of antibiotics use. According to the Egyptian law, antibiotics are
not legally available without prescription, yet this does not happen (Sabry et al., 2014),
which contributes significantly to the prevalence of SMA.
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1.7 Determinants of SMA
1.7.1 Education & Place of Residence
Education contributes to improvement and understanding of healthcare issues and it is
linked to self-medication, especially with antibiotics and patients who are well educated
are expected to have a better understanding of what antibiotics really are and their side
effects (Shehadeh et al., 2016). Most evidence shows that with higher level of education
and awareness there is less SMA (Moise et al., 2017). In England, public knowledge and
behavior towards antibiotic use is associated with level of education whereas, people with
lower educational qualifications displayed less knowledge about antibiotics use and AMR
(McNulty et al., 2007). In Lithuania, place of residence (urban and rural) was significantly
associated with SMA (SMA being higher in urban areas) (Berzanskyte et al., 2006).
Another study in Lithuania also showed that and 26.0% of Lithuanian thought antibiotics
are effective against viral infections (Pavydė et al., 2015). In Italy, higher education was
also associated with more awareness of AMR and knowledge about antibiotics safety
(Napolitano et al., 2013). Education level and science background play a role in SMA
prevalence in Nigeria where women are taking antibiotics for the treatment of menstrual
symptoms where lower levels of education, and non- science background were
significantly linked to high prevalence of SMA (Sapkota et al., 2010).

Prevalence of SMA in the Middle East (Iran, Turkey, Saudi Arabia, United Arab
Emirates (UAE), Kuwait, Oman, Yemen, Jordan, Syria, Lebanon, Egypt and Israel) is very
high (Khalifeh et al., 2017). Most of the countries in the Middle East showed an inverse
relationship between SMA and level of education, where lower levels of education meant
an increase in prevalence of SMA (Alhomoud et al., 2017). One common factor for SMA
among all these countries was access; most patients could get antibiotics from pharmacies
without a prescription due to poor regulation (Cheaito et al., 2014). Other factors, such as
the belief of some communities in the Middle East that antibiotics accelerate recovery and
treat any infection was also observed (Khalifeh et al., 2017 & Alhomoud et al., 2017).
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In Kuwait, Syria and Oman, education level is significantly associated with SMA
(Awad & Aboud, 2015; Barah & Gonçalves, 2010; & Jose et al., 2013). In Kuwait 47%
did not have knowledge on AMR and had poor knowledge regarding use, safety, and
resistance of antibiotics (Awad & Aboud, 2015) which is interesting because 87.5% had
high level of education (bachelor’s degree and higher) and 12.5% only had lower education
level (completed secondary school or less). Being male, younger individuals, low and
medium income, and lower educational status (high school certificate or less) showed high
SMA and little knowledge about antibiotics according to a study done in Kalamoon, Syria
(Barah & Gonçalves, 2010). In Beirut, 80.2% of respondents knew that antibiotics are antibacterial but 73.5% of them did not know that antibiotics were different than anti-viral
(Mouhieddine et al., 2015). Interestingly in Abu Dhabi, Sudan and Alexandria, Egypt, rates
of SMA were higher among those with higher level of education (university degree and
higher) (Abasaeed et al., 2009; Awad et al., 2005; Sallam et al., 2009). Additionally, 82.4%
of pharmacists in Alexandria mentioned that lack of knowledge among patients on the
active ingredients of a specific brand is the major reason for the increase in non-prescribed
medication use (Elhoseeny et al., 2013). Kandeel et al., 2014, revealed that some of the
determinants affecting patients’ use of antibiotics for ARI were mainly patient preference
in adults and in case of younger patients their caregivers (parents) also preferred antibiotics
thinking that they can be used as a prevention for common cold (Kandeel et al., 2014).
1.7.2 Sanitation in low-income countries
Poor hygienic conditions associated with lower socioeconomic class facilitate the
transmission of vectors and pathogens which causes long-term illness that further
exacerbates poverty by diminishing productivity (Bhutta et al., 2014). In Poland,
socioeconomic status, and sanitation increase the risk factors for transmission of
Helicobacter Pylori (Łaszewicz et al., 2014). The recent Ebola outbreak in West Africa
seemed to be associated with lower socioeconomic levels whereas infection emerged and
occurred far more frequently in poorer areas within Liberia (Fallah et al., 2015). Sanitation
plays a role in recurrence of infections, and consequently increases the antibiotics
consumption. Poor sanitation and hygiene, which characterizes what most people under
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the poverty line in the developing world encounter,, increases the risk of water-borne
diseases (Garchitorena et al., 2017). Findings from Alvarez-Uria et al., (2016) shows that
sanitation and poor hygiene in developing countries represent great challenges for
combating AMR because the spread of resistant organisms can occur easily through poor
hygiene and improper sewage systems. Diarrheal infections in Dakahlia were highly
related to poor hygienic conditions which correlated significantly with the incidence of
diarrhea (El-Gilany & Hammad, 2005). In Dakahlia, antibiotics were the most used
medications for diarrheal infections among children, although they were not as effective in
treating infections (because of reoccurrence) or symptoms (El-Gilany & Hammad, 2005).
In Alexandria, 38% of the health units and centers’ staff received training regarding
injection safety and sterilization practices and only 42.2% of the staff who dealt with
medical waste had access to gloves (Elhoseeny & Mourad, 2014). Prevalence of infection
of Helicobacter Pylori in Egypt was twice as high in the rural region than in the urban one
(Awdalla et al., 2010). These hygiene practices contribute to the AMR crisis in Egypt. In
developing countries where access to clean water and hygienic environment is a challenge,
there is a high probability of infection transmission.

1.7.3 Socioeconomic Level & Poverty
Poverty has been cited by the WHO as a main factor causing the quick development of
AMR (WHO, 2004). A comprehensive study done in 2006 in 19 European countries
indicated that prevalence rates for SMA were the highest in Eastern Europe (Romania
and Lithuania), followed by southern Europe (Malta, Spain, and Italy) Europe and the
lowest rates of SMA were in northern and western (the Netherlands and Sweden)
Europe (Grigoryan et al., 2006). These data indicate that the countries’ income and the
socioeconomic level might be a major determinant for SMA. Another study in five
European countries showed high increase of antibiotic prescription for children and
adolescents especially in the winter months for mostly viral infections, Italy had the
highest rates followed by Germany, the UK, Denmark and the Netherlands (Holstiege
et al., 2014). In Lithuania, 61% of people had little knowledge about what antibiotics
do and 26% of them identified antibiotics as a therapy effective against viral infections
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(Pavydė et al., 2015). However, in Sweden, only 19.1% who agreed that antibiotics cure
common colds/ viral infection (André et al., 2010). Sweden is a country with a much
high-income than Lithuania (The World Bank, 2017) and this is high and low-income
ratio relates directly to the rates of SMA. In Lithuania people from rural areas used 1.79
times more non-prescribed antibiotics than people living in urban areas (Berzanskyte et
al., 2006). According to Morgen et al. (2011), the rate of SMA in Central America was
19% compared to just 3% in Nordic countries. These data support the relationship
between country’s high-income status and the socioeconomic level as a determinant of
the SMA rate and misuse of antibiotics.

LMICs have much higher rates of infections than high income countries,
whereas the prevalence of health-care-associated infections is 15·5 per 100 patients,
twice as high as numbers reported in Europe and the USA (7.1 per 100 patients),
furthermore, infections associated with health-care setting in LMIC is 3 times higher
than in the USA (Allegranzi et al., 2011). Furthermore, SMA was found to be 44.1% in
South America where socioeconomic levels are similar to those in the Middle East
where SMA was estimated to be 34.1% (Ramay et al., 2017). Bloom et al., 2015
indicates that poverty is a main factor in making self-medication more common
especially in Lower Middle-Income Countries LMICs (which are defined and listed
according to the World Bank based on gross national income such as Egypt, Sudan, and
Morocco), where a visit to physicians might be unaffordable, and time is saved. In
Guatemala City, same determinants (socioeconomic level and saving time) were among
the main reasons for SMA (Ramay et al., 2017). A comprehensive assessment done in
45 countries revealed indirect association between country’s income and the prevalence
of AMR specifically in relation to three resistant pathogens:
cephalosporin-resistant Escherichia

coli and 3rd

generation

third generation
cephalosporin-

resistant Klebsiella sp and methicillin-resistant Staphylococcus aureus (MRSA).
Findings show that the higher the country’s income, the lower the AMR prevalence for
the three pathogens (Alvarez-Uria et al., 2016). People with low and medium income in
Kalamoon, Syrian and also in Sudan showed high SMA rates and lower knowledge
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towards antibiotics (Barah & Gonçalves, 2010) (Awad et al., 2005). Little research
exists in Egypt with respect to the relationship between poverty and SMA.

1.7 Antibiotic Usage for Gastrointestinal Infections:
Enterobacterial infections are bacteria that infect the digestive tract such as
Klebsiella species and Escherichia coli (Centers for Disease Control and Prevention,
2016). Rezaie et al., 2010 indicated that the likelihood of patients with irritable bowel
syndrome (IBS) who received antibiotics developing clinical symptoms is twice as much
as those receiving just a placebo instead. This research indicates that while antibiotics are
beneficial in relieving short-term symptoms, they change the enteric bacterial flora, and
which might result in emergence of invading infectious and pathogenic species (Rezaie et
al., 2010). Research on gastrointestinal infections in relation to antibiotic usage is scarce
in Egypt. A household survey of diarrhea was done among 4458 children under 5 years in
Dakahlia governorate from June 2002 to May 2003 to determine the prevalence and
determinants of diarrheal diseases. Results showed that the frequency of diarrhea in the
previous two weeks and last 24 hours since the data collection were 23.6% and 8.7%
respectively and 24.3% of children were using rehydration solutions during the diarrheal
episode (El-Gilany & Hammad, 2005). The interesting finding of this research was that the
diarrhea frequency was significantly high among children from rural areas during the
summer season who were 6-24 months, had younger mothers with lower education levels,
and who were unemployed (El-Gilany & Hammad, 2005).

1.8 Significance of this Research:
1.8.1 Economic Burden of AMR
Addressing the prevalence of SMA in Egypt and the factors driving SMA such as
education, socioeconomic level and sanitation is necessary especially in a growing
population of 2 million per year according to the Central Agency for Public
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Mobilization and Statistics (CAPMAS) (UN WPP, 2017). According to WHO (2012),
lack of surveillance data on AMR contributes to poor understanding of the scale of the
problem in the Middle East, as well as absence of large-scale testing for susceptibility
of resistance microbes. According to European Center for Disease Control ECDC
(2010), four of 26 (15%) LMICs have implemented surveillance systems and provided
guidelines for health-care-related infections at the national level. Out of the total 147
developing countries, only 23 countries (16%) have reported having a functional
national surveillance system for health-care acquired infections however Egypt is not
one of them (WHO, 2010). This lack in epidemiological data makes it hard for the
involved stakeholders to view the impacts of AMR and the magnitude of the crisis in
the Middle East. This study is also significant in terms of understanding the economic
burden on developing countries. In the United States - a developed country- the
economic burden from the healthcare-setting infections associated with hospitalization
from resistant infections is calculated to be around $20 billion and another $35 billion
annual cost estimated as lost productivity and workforce (CDC, 2013) in addition to
8 million hospital days extra (Roberts et al., 2009). The associated cost of treatment for
infectious diseases in general in Europe is estimated to be 1.5 billion euros per year for
25,000 patients (ECDC, 2009). The economic burden of AMR and health-setting
associated infections is not known in developing countries because of the lack of data
(Miller-Petrie & Gelband, 2017). In Europe, around 7 billion Euros is estimated to be
the cost of health-care associated infections alone and 37,000 death cases annually
(ECDC, 2009). Some numbers of some of the economic burden is available in Mexico
whereas, the ICU-related infections cost around US$12,155 per case for bloodstream
infections. Moreover, in Argentina, the cost was US$ 4888 and US$ 2255 for catheterrelated bloodstream infection and health setting-associated pneumonia respectively
(Arabi, 2008 & WHO, 2010). Infections with resistant organisms not only result in
greater severity and higher rates of morbidity and mortality, but also increase health
care treatment costs and long-range expenses related to research and development of
new drugs (Meyer et al., 2011).
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1.8.2 Antibiotics in Egypt
This healthcare burden can hit any chance for economic development if the issue is untackled. There is an urgent need for surveillance and data collection in the developing
countries on a nation-wide scale whereas AMR is expected to be more prevalent. As a
developing country, Egypt has several health challenges and a population on the rise
(Elgharably et al., 2017). Developing surveillance systems and acquiring data is essential
for estimating the burden of the problem. The need to assess the consumption and the
risks associated with overuse of antibiotics is accordingly very relevant in a populous
country like Egypt in addition to limiting the onset of a public health crisis. Egypt’s
overuse of antibiotics is on the rise in which consumption of broad spectrum penicillin
and Cephalosporins antibiotics has doubled between the period of 2005-2015 in Egypt
(Alvarez-Uria et al., 2016). Therefore, it is expected that AMR would also be more
prevalent as a result. (ResistanceMap, CDDEP). Healthcare system in Egypt is divided
into public and private with the private sector being widespread and fragmented without
any monitoring, regulations, or certification of quality (Regional Health System
Observatory, 2006). This system has many challenges when assessing the AMR situation
on a nationwide scale because the private sector hospitals and clinics are double the
number of the public ones and cannot be ignored in the monitoring of AMR or studying
the rates of SMA.

1.8.3 Purpose of the Study
Although some studies were conducted in Egypt on the spread of antibiotic misuse and
patient knowledge about antibiotic safety, no study investigated if socio-economic factors
are associated with SMA behavior. In addition, many of the studies done on SMA were
not in Cairo. Most of the large epidemiological studies were done on hospital-acquired
infections and AMR prevalence however, less is conducted in terms of community
infections or rate of consumption of antimicrobials. There are four studies done in
Alexandria, Egypt ; three of them (Elhoseeny et al., 2013 & Sallam et al., 2009 & ElNimr et al., 2015) evaluated the use of nonprescription medications in general and selfmedication but it was not focused on antibiotics. However, a very recent publication
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estimating the SMA in Alexandria, showed that 64% of the studied population used
antibiotics without prescription in the last 12 months (El-Hawy et al., 2017). In Minya,
83% of outpatients at government clinic who had a respiratory tract infection had been
prescribed at least one antibiotic and many caregivers (45%) and adult patients (35%)
believed that antibiotics can be used to prevent common cold (Kandeel et al., 2014). In
Cairo, Sabry et al., (2014) found frequent antibiotics being dispensed from pharmacies
without prescription with 61% of the dispensed antibiotics being appropriate for the
indicated symptoms. However, there is less data available in Cairo about SMA. The
purpose of this study is to thus:
1) Estimate the prevalence of SMA in high and low-income areas.
2) Identify the determinants associated with SMA such as poverty/ socioeconomic,
education and sanitation.
3) Identify the types of antibiotics used the most by the two-selected population.
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Methodology
2.1 Study design
The study was designed as a cross-sectional study to investigate the prevalence of antibiotic
consumption and SMA between two different socioeconomic areas in Cairo. A crosssectional study was selected in order to collect data at a specific point in time and thus be
suitable for estimating the prevalence of a disease or a behavior (Setia, 2016) - in this case
SMA. This type of study is also suitable for population-based investigations which can be
conducted in a time-efficient manner, and is inexpensive (Thelle & Laake, 2015). In a crosssectional study, the researcher measures the exposure (in this study, the socioeconomic
factor) and the outcome (which is SMA) of a disease at the same time, unlike cohort studies
and case control which involve participants who have either been exposed or have the
outcome, respectively (LaMorte, 2016). Cohort studies selects participants who are similar
in everything except one group is exposed to a certain factor and the others are not exposed,
for an extended period of time to observe the development of a disease/outcome (Thelle &
Laake, 2015). On the other hand, case-control studies investigate certain populations/groups
with a disease (outcome) and compare it with others who do not have this outcome in order
to identify the risk factors/exposures that caused or were related to the disease/ outcome
(LaMorte, 2016). Cross-sectional studies examine both exposure and outcomes at the same
time (Setia, 2016), prepare for further causality investigations and mainly estimates the
prevalence of a disease/outcome like SMA in this research.

2.2 Questionnaire Selection
After selecting the research question, different research papers examining prevalence of
SMA in different settings and communities were reviewed to select an appropriate
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questionnaire for the study. Researchers were contacted from Lithuania, Jordan, Lebanon,
and Egypt to obtain relevant questionnaires for scrutiny. Elhoseeny et al.’s 2013
questionnaire in Alexandria examined pharmacists’ behavior and opinion rather than
patients and was thus omitted. In Cairo, Sabry et al.’s 2014 survey studied antibiotics
dispensed from pharmacies with focusing on the appropriateness/symptoms of the patients
more than on SMA. Kandeel et al., 2014’s research in Minya, Egypt on patients’ attitudes
using antibiotics was a qualitative study rather than quantitative. Mouhieddine et al’s, 2014
questionnaire was more on the prevalence and knowledge about antibiotics rather than selfmedication. Sawair et al.’s, 2009 research questionnaire from Jordan were close-ended,a
criterion needed to give clear precise answers especially in this study’s comparison of
particpants from two districts with different backgrounds and educational levels (See
Appendix A). Therefore, Sawair’s questionnaire was selected. Sawair’s questionnaire was
composed of seventeen questions. The first section (six questions) examined demographic
information of participants, andthe second section (composed of four questions) inquired
about perceived health, chronic diseases, having health insurance including type and
coverage, and smoking status. The third section examined antibiotic consumption in the
last six months without a physician consultation, symptoms for taking antibiotics, type and
source of antibiotics, and reasons for self medicaiton.

2.3 Consultation with El-Zanaty & Associates
After selecting the questionnaire, a consultation was made with El-Zanaty & Associates, a
research agency involved in conducting large scale research.. El- Zanaty also is the
implementer of the Demographic Health Survey (DHS), a nation-wide representational
survey providing data on population and health in Egypt, funded by US Agency for
International Development (USAID). Dr. Fatma El Zanaty, director of El Zanaty
Associates*i, kindly reviewed and commented on the questionnaire which greatly helped in
fine-tuning the questions. Dr. Zanaty explained that some of the questions should be divided
into two questions for clarity and precision. Below are the details for the modifications.

2.4 Modifications and Re-Structuring the Questions
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The modified questionnaire had 31 questions (See Appendix B), compared to 17 questions
from the original study by Sawair et al. (2009). The first part was designed to obtain
demographic information of the interviewees such gender, education level (divided into six
categories), income (divided into six categories), and marital status (divided into four
categories). The second part of the questionnaire had questions about consumption of
antibiotics in the last six months by the interviewee or for his/her dependents (children),
followed by a question on self-medication and reasons behind this. The questionnaire also
included a range of symptoms that triggered patients/interviewees to consume antibiotics,
whether through a physician’s prescription or self-medication. Antibiotics consumed were
also asked about and a list of all trade names were provided for interviewees to select from
and to select more than one type if applicable. The trade names of antibiotics were listed in
the questionnaire according to their generic category/ active ingredient so an understanding
of the most consumed types of antibiotics can be provided.

The difference in the number of questions between the modified questionnaire and the
Jordanian one is the addition of subdivision questions that are further investigating the original
questions in the Jordanian study in a more simplified way This subdivision and simplification
of questions was also recommended by Dr. El Zanaty for accommodating the diversity
between the low-and high-income areas with different educational levels and backgrounds.
According to Storms et al., (2017), people with limited literacy and low education have
difficulties in comprehending vocabulary, sentence structure and the decision process during
health questionnaires, therefore minor changes were done to facilitate interpretation and
understanding. The following are the details of all the modification and changes in the
questionnaire

1.

Question 1: The residential area of the participant was added since it was the most

important inclusion criteria; the study’s participants are divided into low-income and highincome areas. This question was also in Sawair et al., 2009, however it was made the first
question in this study.
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2.

Questions 2, 3 and 4: These three questions were on age, gender, and marital status

and all three of them were adopted verbatim from Sawair et al.s 2009 questionnaire.
3.

Question 5:A polar question (yes or no answer) about having children, newly

incorporated with Dr. El Zanaty to learn if participants’ self-medication behavior is correlated
to them having children, since antibiotics consumption was to be measured in the family.
4.

Question 6: asked about how many children participants had, given participants

answered the previous question positively (having children) to understand if also it correlated
with SMA.
5.

Question 7 and 8: These two questions inquired about level of education and

employment status, and remained unchanged from the original questionnaire.
6.

Question 9: Examined participants’ occuptation as a follow up to uncover

occupational differences between the two areas; a newly added item.
7.

Question 10: The monthly income of the family was the same as Sawair et al., 2009

questionnaire, however changes to the set of answeres were made in order to reflect salary
range in Egypt (CAPMAS, 2015). Salaries ranged from less than 1500 EGP (84 USD) to
12000 EGP (672 USD) and above. (See Appendix B).
8.

Question 11 and 12: Examined self-perceived health (good, intermediate and poor)

and the presence of any chronic diseases. Originally, they were presented as one question in
the Jordanian version, and this question was thusdivided into two sets of questions for
simplicity.
9.

Question 13 and 14: Inquired about having health insurance, and the percentage of

coverage. Sawair et al., 2009 had both questions as a single question, and was divided in this
study for simplicity.
10.

Question 16: A yes/no question about smoking, adopted as is from the original

questionnaire .
11.

Question 17, 18, 19 and 20: Investigated the consumption of antibiotics by the

participant himself/herself or by his/her children and care receivers (such as eldely mother or
father) and if they self-medicated or they consulated a physciain. The original questionnaire
combined four questions in one by simply asking if participants took antibiotics in the last six
month without consulting with a physician. The reason for dividing this question into four
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was to provide clarity on whether study subjects took antibiotics in the last six months with
or without a

consultaion of a physician. Therefore to simplfy questions for the two

populations in Egypt, questions were selected to be simple with a yes or no answer. Moreover,
two of this study’s objectives were to estimate the prevelance of antibiotic consumption
whether by a prescption or through self-medication, and to estimate the prevelance of SMA.
Therefore, these four questions first asked if the participant consumed antibiotics in the last
six months and if not, then did his/her children or care receivers (family) had any antibiotics
in the same period, followed by the age of children or care receivers and finally, asking if they
decided to self-medicate themselves or their care recievers with antibiotics (without a
physician consultation). Breaking this question down was necessairy to differentiate between
consuming antibiotics by a physician or a pharmacist and self-medicating without
prescription.
Question 21: Investigated the reasons behind SMA. Seven reasons were presented
(adopted from Sawair et al., 2009) and these seven items included :

12.

-

Cost of physician

-

Because of no health insurance

-

Less time consuming than doctor’s visit

-

Previous experience with similar illness

-

Hate visiting doctors

-

No doctors nearby or health units

-

Others, ________

Question 22: Examined who prescribed/advised participants to take antibiotics and

unlike in Sawair’s questionnaire which asked about the source of antibiotics.
13.

Question 23:

Investigated the physical symptoms that led participants to use

antibiotics (whether through going to the doctor or by self-medicating), a multiple choice list
adopted from the original questionnaire without modifications.(See Appendix A).
14.

Question 24 and 25: looked at frequency and duration of antibiotics taken compared

to recommended guidelines, also in the original questionnaire..
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15.

Question 26: Anew question added to assess public knowledge of the the effectiveness

of antibiotics in treating bacterial and viral infections. This question was developed through
consultation with Dr. El Zanaty.
16.

Question 27: was adopted from the original questionaire to address if participants ever

changed physicians for getting antibiotics prescription.
17.

Question 28, 29 and 30: New items that asked participants whether or not they took

medications for diarrhea and contispation in the last three months, as well as history of ulcers.
These set of questions were designed to estimate the prevalence of gastrointestinal complaints
between the low and high-income areas.
18.

Question 31:Adopted from the original

with some modifications. ,Initially,

participants were asked to mention the type of antibiotics they were taking (Pencillin,
Amoxicillin, or Metronidazole), so for the diverse range of Egyptian participants, the trade
names of each category of antibiotics that are commonly sold in Egypt were listed. This list
was gathered from three pharmacies in Cairo for verification (list can be found in the
questionnaire). Next to the trade name of the antibiotics is another list of the generic type for
analysis. An extra option “Do not know” was added assuming that not all participants in the
two areas will know or remember the type/name of antibiotics they took.

2.5 Selection of the Areas
Selection of the two areas was done based on the Geographic Information System and areabased physical deprivation index (APDI) which divides Cairo into 634 districts (each district
is defined as a small size area of 0.5 km²). The APDI is an index developed by Khadr, et al.,
2010 to assess the deprivation level of the areas in Cairo, also tackling the challenge of
defining a slum area. This APDI index allowed the ranking of all the 634 districts according
to three broad socioeconomic levels namely low, medium, and high, with the low referring
to the most deprived areas (See Appendix J). The methodology for constructing the APDI
was based on a set of criteria that could be measured by remote sensing: informality, high
density, irregular morphology, spatial clustering and other land use activities and important
landmarks (Khadr et al., 2010). These criteria were selected because they can be measured
using remote sensing technology and also they reflected the five criteria developed by the
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UN Habitat for the definition of a slum area (concentration of housing units, lack of
sanitation, overcrowding, old structures and lack of water access) (UN Habitat, 2008). A
contact was made with Dr. Zeinab Khadr, a statistics professor at the Social Research Center
(SRC) at AUC, to randomly select two areas (a low and high area) from the index. Dr.
Khadr kindly provided two maps (See Appendix F) for low and high areas and each map
covers 4 districts (Total size of the four districts is 2 km). The 4-low level districts are
Shagret Mariam, El Matarya El Bahria, El Matrya El Qablia, El Matrya El Gharbia 1. The
other 4 high level districts are Maadi Al Sarayat El Sharqia 1, Maadi Al Sarayat El Sharqia
2, Maadi Al Sarayat El Sharqia 3, and Maadi Al Sarayat El Sharqia 4. These areas were
randomly selected from the databases containing the 634 districts by Dr. Zeinab Khadr
using Excel. The sample size selected for each area (high and the low) was 400, so a total of
800 individuals was the target for the study have been randomly interviewed.

2.6 Consultation with the Social Research Center (SRC) at AUC
Dr. Khadr and Mr. Mohamed Hassan, from the SRC at AUC kindly provided two field
researchers (Mahmoud Radwan and Fayrouz who work as part-time data collectors with
AUC’s SRC) to help with data collection and interviews of the targeted number (800
participants). The researchers were informed and trained regarding the questionnaire and the
research objectives of the study. The first day of field work involved monitoring and follow
up with the field researchers on understanding the questionnaire and providing feedback on
their work such as further explaining the goal of the research to participants and informing
participants about the consent form. Following training day, pre-test was conducted with
twenty participants.

2.7 IRB approval & Pre-assessment
Before submitting the questionnaire to the Institutional Review Board (IRB) at AUC for
approval, the National Institute of Health NIH’s Web-based training course “Protecting
Human Research Participants” was completed as a requirement for conducting a
questionnaire-based study with human subjects. The questionnaire was then submitted to the
IRB committee at AUC along with the consent form in Arabic. Obtaining IRB approval
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lasted around a month of review and editing. Following the IRB approval, a pre-assessment
was made prior to data collection, to assess validity and adjust the questions and the
language accordingly with randomly selected participants. The pre-test was done for twenty
interviewees in one day from 12pm to 4 pm in a randomly selected pharmacy in Maadi, and
edits in the language of the questionnaire and their order were made accordingly then these
changes were communicated with the field researchers. Based on this pre-test, some
participants were not sure of their health insurance coverage and some had less than 50%
(question 15 - What is the type of health insurance coverage do you had?) so two options
were added: “Do not know” & “less than 50%”. In question 23, when asked about physical
symptoms, some participants added constipation, eye problems, nausea and anal fissure, so
these symptoms were also added to the multiple-choice list. The residency question “Where
do you live?” was previously number 10 on the questionnaire but it was moved to be
question number one since it was one of the criteria for selecting participates (which is
based on their residency in either high or low-income areas).Selection of participants
(including criteria) was based on their area of residency whether the low or the high-income
area so if participants were not from the areas selected, they would be excluded. As a final
step, all questions and answers were coded with numbers for the quantitative analysis on
SPSS 21.0.

2.8 Selection of Pharmacies
All pharmacies selected were non-chain pharmacies to ensure the consistency of the
methodology in both locations, since Shagret Mariam did not have any chain pharmacies.
Selected pharmacies were all locally owned. The methodology of selection was based on
randomly walking and checking the existing pharmacies located within the selected areas on
the map, then visiting the pharmacies and asking their permissions for conducting the study
with the non-chain as the main criterion for inclusion. Selection of the pharmacies was
based also on the approval of the owners for conducting the study. A total of seven
pharmacies were visited in Maadi (Dr. Mariam pharmacy, Dr. Mai pharmacy, Degla
pharmacy, Ahmed Sameh pharmacy, El Yamani pharmacy, El Mashreq pharmacy, and New
Maadi pharmacy). The streets in Maadi where the selected pharmacies were located on
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Lasalki Street, Street 257, Street 205, and Street 78. In Shagret Mariam, the eight
pharmacies visited were (Shagret Mariam pharmacy, El Shefaa El Haditha pharmacy, El
Sanabel pharmacy, Dr. Hisham’s pharmacy, Dr. Philip’s pharmacy, Dr. Said pharmacy, Dr.
El Nemr pharmacy, and El Noor pharmacy) and all of them were spread out on seven streets
within the selected map. The streets in Shagret Mariam were; El Matarawy Street, Shagret
Mariam Street, Menyet Matar Street, Fadel Street, El Balsam Street, El Obour Street, and
Badr Street. The research were explained to the pharmacy owners, and approval for
conducting the questionnaire to visitors within their premises was obtained. Interviews were
then conducted simultaneously in both the low and high areas between 12 pm till 6-7 pm in
the evening.
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Figure 1 Map showing the 2-km of the selected area of Maadi which represents the high-income area. The map shows 5 pharmacies
located in 5 streets. The 1st pharmacy is called Dr. Ahmed Sameh pharmacy located at Street 78. The 2 nd one is called Dr. Mahmoud
El Khouly pharmacy on Street 231. The 3 rd one is El Kholoud pharmacy located on Street 233. The 4 th pharmacy is El Kinawy
pharmacy on Street 199 and the 5th pharmacy is called Degla pharmacy on Street 205.
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Figure 2 Map showing the 2-km selected area of Shagret Mariam which represents the low-income area. The map shows 7 streets and
8 pharmacies. El Matarawy Street has two pharmacies (Dr. El Nemr pharmacy and El Noor pharmacy). In Shagret Mariam Street,
the pharmacy is called Shagret Mariam. The 4 th one is Dr. Hisham pharmacy located in Menyet Matar Street. In Fadel Street, the 5th
pharmacy is called El Shefaa El Haditha. The 6 th pharmacy is El Sanabel pharmacy in El Balsam Street. The 7 th pharmacy is Dr.
Said pharmacy and located in El Obour Street and the 8 th pharmacy is Dr. Philip pharmacy in Badr Street.
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2.9 Data Collection
The total sample was 802 individuals with a total margin of error of 3.46% and 95%
confidence level. Data collection took eleven days with an average of 40 to 50 interviews
per day in each location. Interviewees were customers who were asked to participate
upon leaving the above-mentioned pharmacies. Questionnaires were numbered for each
location and the response rate was calculated. Data was collected from September 13th
to24th, 2017. The questions were asked orally to interviewees and the consent form was
explained verbally and the answered were also collected verbally. The reason the
interviews were done verbally was because participants had different educational
backgrounds in the low and high-income areas and it was expected that not everyone can
read and write. Additionally, health literacy varies from one person to another and with
lower education too (Storms et al., 2017). Field researchers did obtain the consent
verbally and wrote it down followed by the writing down the answers that were asked
also verbally to participants. Field researchers were trained to be consistent in wording
the questions to avoid any misunderstanding or bias.

2.10 Data Entry and Validation
A total of 402 questionnaires were completed in Maadi, and another 400 in Shagret
Mariam area. Data were entered manually on an Excel sheet. All questions and answers
were coded with numbers for quantitative analysis on SPSS 21.0. Micro-editing and
validation of the data has been made. Micro-editing involved checking any missing data,
any errors, and the consistency of data to each individual questionnaire. Data was
validated and transformed from an excel file to an SPSS 21.0 file. Data validation was
done by reviewing the excel sheets for errors and missing fields. Later, when it was
transferred to SPSS 21.0, another check for error character was made by manual scanning
then by testing some basic descriptive analysis. Statistical edits also on SPSS 21.0 were
done through identifying missing or non-applicable fields and correcting invalid
characters.
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2.11 Data Analysis – Descriptive analysis
After data entry and validation, basic descriptive analysis was done to highlight the
sample characteristics such as percentage and frequency of male and female participants,
marital status, educational levels, income of the family, and employment status.
Frequencies were generated under descriptive statistics in SPSS 21.0.

2.12 Recoding Variables
A new variable was created to estimate the total antibiotic consumption per family
because in the questionnaire there were two questions/variables asking about antibiotic
consumption. So, these two variables (antibiotics consumed in the last six months, and
antibiotics consumed for children/care receivers were combined into a new variable
called “Total consumption of antibiotics”. The purpose of combining these two variables
was to account for not only the consumption of the questionnaire-taker but also if he/she
has given antibiotics to someone they provide care for in the household. After running
descriptive analyses for the data, some variables such as education, employment status
and level of income were recoded into different new variables. Education had six values
(Graduate, University degree, High school, Preparatory school, Primary school, and no
formal education) and the statistics showed that majority of the sample in both areas
Maadi and Shagret Mariam fell in the ‘University degree’ or ‘high school degree’
categories. The six categories of education were thus shortened to three values only (No
education, High school degree, and University or higher), also useful for analyses such as
Chi-Square. Employment status was also divided into three values instead of five,
(Working, Retired or unemployment or student, and housewife) based on the original
questionnaire. Level of income consisted of seven intervals, however most of the Maadi
sample fell in the highest four intervals (6000-8000, 8000-10000, 10000 – 12000, and
More than 12,000) and the majority of the Shagret Mariam sample were in the lowest
intervals (Less than 1500, 1500-4000, and 4000-6000). Therefore, the seven intervals
were recoded into main categories (low income and high income).
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2.13

Significance & Correlation

T-test of percentage was performed to assess differences between the two areas for
significance using SPSS 21.0. Variables examined included

1.

Status of self-report health

2.

Having a chronic illness

3.

Having children

4.

Having health insurance

5.

Prevalence of smoking

6.

Prevalence of antibiotic consumption in adults

7.

Prevalence of antibiotic consumption in children/care givers

8.

Prevalence of total consumption of antibiotics per family

9.

Prevalence of SMA

10.

Knowledge about antibiotics

11.

Frequency of the dose of antibiotics

12.

Duration of the antibiotics

13.

Going to another physician for antibiotics

Testing significance between the two areas also regarding the following variables have
been conducted using Chi-square
1.

Residency and education

2.

Residency and employment

3.

Residency and income

Testing variables (nominal or categorical) for significant correlations was done using
Chi-square test of independence. Variable pairings included:
1.

SMA & health insurance
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2.

SMA & employment status

3.

SMA and gender

4.

SMA & marital status

5.

SMA & income

6.

SMA & residency (socioeconomic level)

7.

SMA & education

2.15

Logistical Regression

To understand the factors causing and contributing to the prevalence of SMA, logistical
regression was done on SPSS 21.0. Multiple variables were put into the test to generate
more than one regression model to understand the effect and relationship between the
different variables.
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Results
3.1 Demographic Background
Table 1 below provides a comparative descriptive analysis for the two samples providing some
demographic information. A total of 802 questionnaires were completed. The total response
rate was 66% (n = 609) in Maadi where 609 people were approached to participate in the
questionnaire and only 402 agreed. In Shagret Mariam the response rate was 82% (n = 488)
where 488 were approached and 400 agreed to participate. Women made up the majority of
respondents, 61.2% *(n =246) in Maadi and 65% (n =260) in Shagret Mariam. In Maadi, the
average age of respondents was 42 years old and in Shagret Mariam, average age was 38 years
old. Moreover, 81% (n = 325) of respondents in Maadi were married, compared to 65% (n =
261) in Shagret Mariam. In Maadi, 82% (n = 331) had children, while 66% (n = 264) in
Shagret Mariam had children, respectively which was found to be significantly different
between the two areas (p = 0.000) using t-test of percentage.

3.2 Education and Income
Educational level varied significantly between the two locations (p = 0.000); in Maadi 74%
(n = 298) had a university education, compared to 31.5% (n = 126) in Shagret Mariam. The
majority of participants from Shagret Mariam had a high school degree 48.5% (n = 194),
followed by a university degree 31.5% (n = 126), while 15.5% (n = 62) had a preparatory
school degree. In Shagret Mariam, 4.6% (n = 9) of respondents had no education (or
primary) compared to none in Maadi. With respect to employment, there was also a
significant different in the employment levels between the two areas (p = 0.000), 51.5% (n
= 207) of Maadi residents were employed compared to 45.8% (n = 183) in Shagret Mariam.
Additionally, 1.7% (n = 7) of Maadi residents and 10% (n = 40) of Shagret Mariam
residents were unemployed. Additionally, 33.8% (n = 136) of Maadi were housewives
compared to 38% (n = 151) in Shagret Mariam. In Shagret Mariam, the most reported
salary range was between 1500-4000 EGP for 61% of the sample (n = 243) and none from
Maadi had this salary range. The second most reported salary range in Shagret Mariam was
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between 4000-6000 EGP where 33% (n = 130) had this salary range compared to 1% (n =
4) in Maadi. On the other hand, the most common salary range in Maadi was 10,000-12,000
EGP representing 41% (n = 165) and none had this salary range in Shagret Mariam. The
second most reported salary range in Maadi was more than 12,000 EGP representing 37.3%
(n = 150) compared to none in Shagret Mariam. Also, 16.7% (n = 67) of Maadi residents
earned between 8000 -10,000 EGP compared to none in Shagret Mariam. Overall, the
salaries varied significantly between the two locations (p = 0.000); the salary bracket of
1500 – 6000 EGP represented more than 90% of salaries in Shagret Mariam. On the other
hand, in Maadi the salary bracket of 8000-more than 12,000 EGP represented more than
90% of the sample.

3.3 Health status & Insurance
There was a significant different in the self-reported health between Maadi and Shagret
Mariam (p = 0.047), whereas 88.6% (n = 356) of Maadi respondents believed their health
was good compared to 92.5% (n = 370) in Shagret Mariam and 11.2% (n = 45) in Maadi
thought it was intermediate (not too good and not too bad) compared to 7.5% (n = 30) in
Shagret Mariam. In Maadi, 13.4% (n = 54) said they had a chronic illness compared to
7.5% (n = 30) in Shagret Mariam which was also significantly different in the two areas (p
= 0.006). The most common chronic disease in both areas was high blood pressure, present
in 66% (n = 37) of Maadi residents and 77.4% (n = 24) of Shagret Mariam residents.
Diabetes is the second most common chronic disease, reported by 57.1% (n = 32) of Maadi
residents and 45.2% (n = 14) of Shagret Mariam residents. Heart disease was prevalent in
22% (n = 7) of Shagret Mariam residents while only 7.1% (n = 4) of Maadi residents.
Additionally, 3.6% (n = 2) of Maadi residents had high levels of cholesterol compared to
none in Shagret Mariam.

Having health insurance was reported by 51.2% (n = 206) of Maadi residents and
by 12.5% (n = 50) of Shagret Mariam reflecting a significant difference between the two
areas (p = 0.000). A closer investigation of health insurance revealed that 41.5% (n = 86)
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of Maadi respondents with health insurance had 80-90% coverage, compared to 16% (n =
8) in Shagret Mariam. Also, 25.1% (n = 52) of Maadi respondents had a 50-70% coverage
had this coverage compared to 54% (n = 27) in Shagret Mariam. With respect to the 100%
coverage, 24.6% (n = 51) of Maadi respondents had it and 12% (n = 6) only in Shagret
Mariam. In Shagret Mariam 18% (n = 9) had health insurance coverage below 50%
compared to 7.2% (n = 15) in Maadi. Regarding smoking, 34.3% (n = 138) of Maadi are
smokers compared to 23% (n = 92) in Shagret Mariam and 2% (n = 8) in Maadi are exsmokers compared to 0.8% (n = 3) in Shagret Mariam. From these health insurance data,
Maadi respondents who had a health insurance 51.2 % (n = 206) were almost double those
who had insurance in Shagret Mariam 12.5% (n = 50). In Maadi, the most commonly
reported health insurance coverage was the 90-80% coverage plan. In Shagret Mariam, the
common coverage plan for those who have health insurance was the one with 50-70%
coverage.
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Table 1 Descriptive analysis of the sample in the two selected areas
Maadi (1)

Shagret Mariam (2)

Variable

402

400

Average age
(years)

42.33

37.52

Males

156 (38.8%)

140 (35 %)

Females

246 (61.2%)

260 (65 %)

Single

61 (15.2 %)

115 (28.8 %)

Married

325 (80.8 %)

261 (65.3 %)

Divorced

3 (0.7 %)

14 (3.5 %)

Widow

13 (3.2 %)

10 (2.5 %)

Having
children

Yes

331 (82.3 %)

264 (66%)

0.000***

Education
Level

Graduate

24 (6%)

0.0

0.000***

University

298 (74.1 %)

126 (31.5 %)

High school

76 (18.9 %)

194 (48.5 %)

Prep. School

4 (1%)

62 (15.5 %)

Primary

0.0

9 (2.3 %)

No education

0.0

9 (2.3 %)

Working

207 (51.5%)

183 (45.8%)

Retired

17 (4.2%)

3 (0.8%)

Unemployed

7 (1.7%)

40 (10%)

Housewife

136 (33.8%)

151 (37.8%)

Student

35 (8.7%)

23 (5.8%)

Less than 1500

0.0

11 (2.8 %)

1500- 4000

0.0

243 (61.2%)

4000-6000

4 (1%)

130 (32.7 %)

6000-8000

16 (4%)

13 (3.3 %)

8000 – 10,000

67 (16.7%)

0.0

Gender

Marital status

Employment
Status

Income (EGP)
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p-value

0.000***

0.000***

10,000 – 12,000

165 (41 %)

0.0

More than 12,000

150 (37.3%)

0.0

Good

356 (88.6 %)

370 (92.5 %)

Intermediate/poor

46 (11.4 %)

30 (7.5 %)

Having
Chronic Illness

Yes

54 (13.4 %)

30 (7.5 %)

Chronic Illness

Diabetes

32 (57.1%)

14 (45.2%)

Heart problems

4 (7.1%)

7 (22.6%)

High blood
pressure

37 (66.1%)

24 (77.4%)

High cholesterol

2 (3.6 %)

0.0

Stomach issues

1 (1.8%)

0.0

Thyroid

0.0

2 (6.5%)

Health
Insurance

Yes

206 (51.2 %)

50 (12.5 %)

Insurance
Coverage

100% covered

51 (24.6%)

6 (12%)

90 -80 %

86 (41.5%)

8 (16 %)

70 -50 %

52 (25.1%)

27 (54 %)

Less than 50 %

15 (7.2 %)

9 (18 %)

Do not know

3 (1.4%)

0.0

Smoker

138 (34.3 %)

92 (23 %)

Non-smoker/ Exsmoker

266 (65.7 %)

308 (77.1 %)

Self-reported
Health

Smoking

*p˂0.05 **p<0.01 ***p<0.0001
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0.047*

0.006**

0.000***

0.000***

3.4 Prevalence of antibiotic use and SMA
In Table 2, 24.1% (n = 97) of participants in Maadi consumed at least one antibiotic in
the last six months and 67.2% (n = 205) of the participants’ children and family members
consumed antibiotics in the last six months as well. In Shagret Mariam, 18% (n = 72) of
the study participants took antibiotics in the last six months and 61.6% (n = 202) of their
children and family members they care for, took also antibiotics in the last six months.
The prevalence of total consumption of antibiotics per family in Maadi and Shagret
Mariam were 75.1% (n = 302) and 68.5 % (n = 274), respectively. Regarding selfmedication in the high-income area as demonstrated in Graph 1, 12.9% (n = 39) did SMA
in the last six months compared to 47.4% (n = 130) in the low-income area who reported
that they did SMA.

Table 2 Consumption of Antibiotics and Prevalence of SMA Practice in the Two
Selected Areas

Variable

Maadi (1)

Shagret Mariam (2)

402 (%)

400 (%)

p-value

Antibiotics consumed in last 6
months

Yes

97 (24.1 %)

72 (18%)

0.033*

Antibiotics consumed in last 6
months (children/family)

Yes

205 (67.2%)

202 (61.6%)

0.140

302 (75.1 %)

274 (68.5 %)

0.037*

39 (12.9%)

130 (47.4%)

0.000***

Total consumption of antibiotics
(Per family)
Self-medication prevalence

Yes

*p˂0.05 **p<0.01 ***p<0.0001
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Graph 1 Pie Chart shows the rate of SMA in the high-income area
of Maadi where as 12.9% of the population practiced SMA in the
last 6 months compared to 87.1% who did not.

Graph 2 Pie Chart shows the rate of SMA in the low-income
area of Shagret Mariam with 47.4% of the population
practicing SMA in the last 6 months compared to 52.6% who
did not.

3.5 Reasons for SMA
As illustrated in Graph 3 and in Table 3 (below), the main reported reason for SMA in
both Maadi and Shagret Mariam was previous experience with similar symptoms,
accounting for 79.5% (n = 31) in Maadi and 89.2% of respondents (n = 116) in Shagret
Mariam. Responses differed with respect to the subsequent most popular reasons for
SMAs between the two residential areas. In Maadi,SMAs were less time-consuming than
physician visits, accounting for 25.6% (n = 10), followed by the cost of physician and
hating to visit the doctor both accounted for 5.1% (n = 2). In Shagret Mariam, cost of
physician visits accounted for 50.8% (n = 66), while another 24.6% (n = 32) of
participants practiced SMA to save time. In Shagret Mariam, hating to visit the doctor
accounted for 6.9% (n = 9) of responses.
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Table 3 – Reasons for SMA in respondents in Maadi and Shagret Mariam
Reasons for SMA

Maadi (1)

Shagret Mariam (2)

402 (%)

400 (%)

2 (5.1%)

66 (50.8%)

No health insurance

0.0

1 (0.8%)

Less time consuming

10 (25.6%)

32 (24.6%)

Experience with similar symptoms

31 (79.5%)

116 (89.2%)

2 (5.1%)

9 (6.9%)

0.0

0.0

1 (2.6%)

1 (0.8%)

Cost of physician

Hate Dr. visits
No nearby physician or Clinic
Other

Reasons for SMA
0.8%
2.6%

Other

0.0%
0.0%

No nearby physician or clinic

6.9%
5.1%

Hate Dr. visits
Experience with similar symptoms

79.5%

89.2%

24.6%
25.6%

Less time consuming
0.8%
0.0%

No health insurance
Cost of physician

50.8%

5.1%
0%

10%

20%

30%

Shagret Mariam (2)2

40%

50%

60%

70%

80%

90%

Maadi (1)

Graph 1 shows the reasons for SMA in both Maadi (colored blue) and in Shagret Mariam (colored
red) and as the graph is indicating, the main reason for SMA was having previous experience with
the symptoms in both areas; Maadi (79.5%) and Shagret Mariam (89.2%). Cost of physician
accounted for the second main reason for SMA in Shagret Mariam with 50.8% however in Maadi,
the second main reason for SMA was that SMA was less time consuming. Cost of physician and
hating to visit the doctor were two reasons for residents of Maadi to SMA accounting for 5.1%. Yet
in Shagret Mariam, saving time came third (24.6%) followed by hating to visit the doctor (6.9%).
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100%

3.6 Perceived Symptoms for antibiotics consumption
In Table 4, fever and common cold were among the most common symptoms in both
Maadi and Shagret Mariam. In Maadi fever accounted for (67.5%, n = 204), followed by
a common cold (62.6%, n = 189) and in Shagret Mariam fever was also the major
symptom for taking antibiotics, accounting for 75.8% (n = 207), followed by having a
common cold 61.2% (n = 167). Having a sore throat was the third most common
symptom in both areas, in Maadi it accounted for (54.6%, n = 165) and 60.1% (n = 164)
in Shagret Mariam.

In Maadi, coughing came as the fourth common symptom and accounted for (48%,
n = 145) and ear ache represented 18.9% (n = 57) followed by dental problems 10.3% (n =
31). Gastrointestinal symptoms also accounted for taking antibiotics, and diarrhea
represented 7% (n = 21), followed by cramping and stomach ache 5.6% (n = 17). Painful
urination was 4.6% (n = 14), eye problems 1.7% (n = 5) followed by other symptoms 4.6%
(n = 14). In Shagret Mariam, coughing was 53.8% (n = 147). Ear ache was also among the
top symptoms accounting for 15.8% (n = 43), followed by having a headache 7.3% (n =
20) and having dental problems 5.9% (n = 16). In Shagret Mariam, diarrhea was 4.8% (n
= 13), and cramping was 11.4% (n = 31). Painful urination accounted for 3.3% (n = 9) and
other symptoms was 8.4% (n = 23).
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Table 4 – Perceived Symptoms for antibiotics consumption
Symptoms for consuming
Antibiotics

Maadi (1)

Shagret Mariam (2)

402 (%)

400 (%)

Fever

204 (67.5%)

207 (75.8%)

Common cold

189 (62.6%)

167 (61.2%)

Sore throat

165 (54.6%)

164 (60.1%)

Cough

145 (48 %)

147 (53.8%)

Ear ache

57 (18.9%)

43 (15.8%)

Headache

29 (9.6%)

20 (7.3%)

Dental

31 (10.3%)

16 (5.9%)

21 (7%)

13 (4.8%)

Cramp _Stomach ache

17 (5.6%)

31 (11.4%)

Painful urination

14 (4.6%)

9 (3.3%)

Eye problem

5 (1.7%)

1 (0.4%)

Skin problem

0

1 (0.4%)

Constipation

0

3 (1.1%)

Blood in stool

0

2 (0.7%)

Bloated

0

0

Nausea

3 (1%)

14 (5.1%)

Anal problem

2 (0.7%)

3 (1.1%)

Dehydration

0

0

14 (4.6%)

23 (8.4%)

Diarrhea

Other
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3.7 Participants’ Behavior
In Maadi, all participants who took antibiotics in the last six months 100% (n = 302) took
the dose as frequently as recommended either by the physician or the leaflet of the
antibiotic. In Shagret Mariam, 98.5% (n = 270) took the dose as frequently as
recommended. Regarding sticking to the duration for the whole course of antibiotics, in
Maadi 99% (n = 299) followed the course of antibiotics as recommended and 93.1% (n =
255) did follow the course in Shagret Mariam. In Maadi, 96.1% (n = 374) said that yes
antibiotics treat viruses and bacteria both and 1.5% (n = 6) said no they do not treat
viruses and bacteria and 2.3% (n = 9) did not know if antibiotics treat viruses and bacteria
or not. In Shagret Mariam 83.5% (n = 334) said yes antibiotics treat viruses and bacteria
both, 1% (n = 4) said no they do not treat viruses and bacteria and 15.5% (n = 62) said
they do not know. In Maadi, 3.5% (n = 14) said they went to another physician to get
antibiotic prescription when the first one did not prescribe them one and 96.5% (n = 388)
said no they did not. In Shagret Mariam, 2.5% (n = 10) said they went to another
physician to get antibiotics while 97.5% (n = 389) said they did not. In Maadi, 35.1% (n
= 141) did took diarrheal medication in the last 3 months and 19.2% (n = 77) did took
constipation medication in the last 3 months while in Shagret Mariam 20.8% (n = 83) did
took diarrheal medication and 3% (n = 12) took constipation medication in the last 3
months. In Maadi, 11.4% (n = 46) had a history of ulcer while it was 6.5% (n = 26) in
Shagret Mariam.

54

Table 5 – Participants behavior for taking antibiotics

Variable

Maadi (1)

Shagret Mariam (2)

402 (%)

400 (%)

Frequency of the dose as
recommended

Yes

302 (100%)

270 (98.5%)

Duration as recommended

Yes

299 (99%)

255 (93.1%)

Antibiotics treat viruses & bacteria

Yes

374 (96.1%)

334 (83.5%)

No

6 (1.5%)

4 (1%)

Do not know

9 (2.3%)

62 (15.5%)

Going to another physician to get
antibiotics

Yes

14 (3.5%)

10 (2.5%)

Diarrheal meds in last 3 months

Yes

141 (35.1%)

83 (20.8%)

Constipation meds in the last 3
months

Yes

77 (19.2%)

12 (3%)

History of ulcer

Yes

46 (11.4%)

26 (6.5%)

3.8 Classes of Antibiotics
Amoxicillin was the most used class of antibiotic in both areas; in Maadi, it accounted for
60.7% of respondents (n = 184) and in Shagret Mariam it was 48.2% (n = 132).
Moreover, in Maadi, 19.1% (n = 58) did not know which type of antibiotics they took and
31.8% (n = 87) of Shagret Mariam did not also know what kind of antibiotics they used.
In Maadi, Penicillin was the second most used antibiotics with 8.9% (n = 27) of the
people using it, followed by Cefotaxime 7.9% (n = 24), Nifuroxazide 5.6% (n = 17), and
Metronidazole and Azithromycin, botheach accounting for 5.3% (n = 16). In Shagret
Mariam, Cefotaxime was the second most used antibiotics after Amoxicillin with 8.4% (n
= 23) of the people using it, followed by Metronidazole 5.1% (n = 14), followed by
Nifuroxazide 4.4% (n = 12) and Penicillin and Azithromycin were 4% (n = 11).
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Table 6 – Antibiotics that are mostly consumed in the two selected areas
Maadi (1)

Shagret Mariam (2)

402 (%)

400 (%)

Don't know

58 (19.1%)

87 (31.8%)

Penicillin

27 (8.9%)

11 (4%)

184 (60.7%)

132 (48.2%)

Metronidazole

16 (5.3%)

14 (5.1%)

Nifuroxazide

17 (5.6%)

12 (4.4%)

Ciprofloxacin

0.0

2 (0.7%)

Azithromycin

16 (5.3%)

11 (4%)

Clindamycin

6 (2%)

2 (0.7%)

Acyclovir

0.0

0.0

Cephalosporins

0.0

0.0

Cefotaxime

24 (7.9%)

23 (8.4%)

Quinolones

0.0

0.0

Fluoroquinolones

0.0

0.0

3 (1%)

2 (0.7%)

2 (0.7%)

3 (1.1%)

Variable

Amoxicillin

Tetracyclines
Aminoglycosides
Co-trimoxazole

0.0

1

(0.4%)

3.9 Significance of Differences between the Two Areas (T-test)
T-test of percentage was done using SPSS 21.0 to assess if there is a significant
difference between the different variables in the two selected areas of Maadi and Shagret
Mariam. The t-test examined the significance difference for the variables (Table 7)
below. Chi-square test was also done to check if there is significant difference between
education levels in the two areas (Table 8) and found a significant difference (p = 0.000).
Another Chi-square was done to assess if there is a significant difference between levels
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of income in the two areas and found a significant difference (p = 0.000). Employment
status was in the two areas was found to be significantly different as well (p = 0.000).

Table 7 showing the p values of T-test of Percentage for Significance on different
variables.
Variables

p Value

Residency and Having children

0.000***

Residency and Self-reported health

0.047*

Residency and Having a Chronic Illness

0.006**

Residency and Having Health Insurance

0.000***

Residency and Smoking

0.000***

Residency and Antibiotics Consumption in Adults

0.033*

Residency and Antibiotics Consumption for

.140

children/care givers
Residency and Total Consumption of Antibiotics per 0.037*
Family
Residency and SMA

0.000***

Residency and Antibiotics treats viruses and bacteria 0.000***
Residency and frequency of taking antibiotics

0.035*

Residency and duration of antibiotics

0.000***

Residency and going to another physician

0.418

*p˂0.05 **p<0.01 ***p<0.0001

3.10 Testing of Significant Correlations
3.10.1 Testing Correlation between SMA and Level of Education
Chi-square test of independence was performed to examine the relation between SMA and
level of education in both areas. The test indicated that there is a significant relationship
between SMA and level of education in general (p = 0.000). When looking at each area, in
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Shagret Mariam only there was a significant relationship; X2 (2) =11.13, p < 0.04). With
lower levels of education, there is a higher rate of SMA in Shagret Mariam. However, in
Maadi, the relationship between education and SMA was found to be insignificant (p =
0.819)

3.10.2 SMA and Residency (Socioeconomic Level)
Another chi-square test of independence analyzed the relationship between residency and
rate of SMA and showed a significant correlation between the two variables where X2 (1)
=82.62, p < 0.00). The rate of SMA was found to be significantly correlated to residency
(socioeconomic level). Significantly higher rates of SMA was found more common in the
low-income area compared to the high-income area.
3.10.3 SMA and Gender
Chi-square test of independence showed insignificant relationship between SMA and
gender where X2 (1) =0.968, p < 0.325).

3.10.4 SMA and Having Health Insurance
Chi-square test of independence showed a significant relationship between SMA and
having a medical insurance where X2 (1) =25.73, p < 0.000).

3.10.5 SMA and Employment
Chi-square test of independence showed insignificant relationship between SMA and
employment where X2 (2) =4.91, p < 0.086).

3.10.6 SMA and Marital status
Chi-square test of independence showed a significant relationship between SMA and
marital status where X2 (3) =15.12, p < 0.002).
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3.10.7 SMA and Income
Chi-square test of independence showed also a significant relationship between SMA and
levels of income where X2 (1) =76.5, p < 0.000).

Table 8 showing Chi-square test results reflecting the significant relationships
between SMA and other variables / Residency and other variables
Chi-square

p-value

SMA and Level of Education

0.000***

SMA and Residency

0.000***

SMA and Gender

0.325

SMA and having health insurance

0.000***

SMA and employment status

0.086

SMA and marital status

0.002**

SMA and income

0.000***

Residency and Education level

0.000***

Residency and Income level

0.000***

Residency and employment

0.000***

*p˂0.05 **p<0.01 ***p<0.0001

3.11 Significant relationships between residency and education, income and
employment
Table 8 above shows chi-square results indicating a significant correlation between
residency and education level (X2 (5) =214.3, p < 0.000). Also a significant correlation
was found between residency and income (X2 (6) =754.7 p < 0.000). Employment also
showed a significant correlation with residency (X2 (4) =37.7, p < 0.000).
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3.12 Logistical Regression – Determinants of SMA
In Table 10, the first regression model shows that income and education have significant
p-values when excluding the residency factor from the model. Reflecting that income and
education are both factors contributing to SMA prevalence. The second model shows
significant values for residency and for education without the income. The third
regression model included income, education and the area of residency which showed in
earlier models significant values. In this third model, when adding the three factors
together, the only factor showing significance is education.
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Regression Model 1
B
Gender
Having children
Having chronic

Regression Model 2
S.E.

Sig.

-.121

.215

.573

.886

Having
children

-.249

.295

.400

.780

1.378 Having
children

.265

.294

.367

1.304

Having
chronic
illness

.237

.351

.499

1.268

.346

.355

.000***

Education (2)

-1.166

.358

.001**

-.363

.231

.117

2.158

.330

.000

.348

Income

.256 Education (1) 1.001
.200 Education (2) .297

.354

.005**

2.721

Income (1) .074

.837

.930

1.077

.233

.202

1.346

Income (2) -.293

.795

.712

.746

Having chronic -.236
illness

.350

.501

.790

-.597

.308

.053

.551

.005**

Education

.018*

Education

.000***

.271

Constant

.760 Gender

.320

-1.610

Exp(B)
1.182

.349

Income (2)

Sig.
.444

.293

.000***

S.E.
.218

-.274

.270

B
.167

1.161 Residency

-1.362

Exp(B)
Gender

.491

Income (1)

Sig.

.000*** .214

.217

Income

S.E.

-1.543 .239

.149

illness

Education (1)

B

Exp(B)

Regression Model 3

.010*

Education
Education -1.086 .361
(1)

.003** .338

.696

Education -.312
(2)

.234

.182

.732

8.653

Residency 1.466

.804

.068

4.330

Constant .660

.880

.453

1.935

.312 Constant

*p˂0.05 **p<0.01 ***p<0.0001
Table 10 Showing 3 regression models. Regression model # 1 - included: Gender, having children, Having chronic illness,
Education and Income. Regression model # 2 – including area, having children, gender, Having chronic illness, and
Education (excluding income). Regression model # 3 - included: area, gender, having children, Having chronic illness,
income and Education).
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Summary of the Results
The main findings of the research are the high prevalence of SMA which was found to be
four times more in the low-income area of Shagret Mariam (47.4% (n = 130) than in the
high-income area 12.9% (n = 39) of Maadi. Total consumption of antibiotics (regardless
of SMA practice) was significantly higher (p = 0.037) in the high-income area of Maadi
75.1% (n = 302) compared to 68.5 % (n = 274) in Shagret Mariam. Significant
correlation was found between prevalence of SMA and the area (residency) (p = 0.00)
where higher rates of SMA was found more common in the low-income area compared to
the high-income area. Another significant correlation was found between SMA practice
and levels of education in Shagret Mariam (p = 0.04) where with lower levels of
education, there was a higher prevalence of SMA. The study also showed that the main
reason for SMA in both areas was having a previous experience with similar symptoms;
79.5% (n = 31) in Maadi and 89.2% of respondents (n = 116) in Shagret Mariam. In the
low-income area, the second main reason was cost of physician 50.8% (n = 66) compared
to saving time 25.6% (n = 10) in Maadi. Amoxicillin was the most consumed antibiotics
in Maadi 60.7% (n = 184) and 48.2% (n = 132) in Shagret Mariam. From running three
different regression models, education always showed significance with other factors.
However, when combining income and education, income also showed significant values
and when combining area of residency with education, area showed significant values.
Yet adding residency and income together in one model did not account for any
significant values.
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Discussion
4.1 Demographic Background
A total of 802 questionnaires were completed with higher response rates in the lowincome area; Shagret Mariam 82% (n = 488) compared to 66% (n = 609) in Maadi. One
of the reasons for lower response rate in Maadi was that Maadi residents seemed to be
more in a hurry, while Shagret Mariam residents would be curious more to stop and
participate. Interestingly, females were more willing than the males to participate in the
study in both Maadi and Shagret Mariam which accounted for 61.2% (n = 246) in Maadi
and 65% (n = 260) in Shagret Mariam. The female researcher was stationed in Shagret
Mariam and the male researcher was in Maadi so it did not affect the gender of
participants because similar percentage of women were found at the two areas.
Educational levels were higher in Maadi than in Shagret Mariam, which was expected
given the different socioeconomic levels between the two areas with being a university
graduate as the majority of Maadi’s 74.1% (n = 298) compared to having a high school
degree 48.5% (n = 194) as the most dominant educational level in Shagret Mariam.
Income varied significantly between the two areas which supported the socioeconomic
difference of the two populations as expected before conducting the study where 94% (n
= 373) of the salaries in Shagret Mariam were below 6000 EGP per month compare to
90% of salaries in Maadi more than 8000 EGP per month. These results reflected the
socioeconomic level difference of the two populations and confirms the categorization of
the APDI index as indicated by Khadr et al., 2010.

4.2 Self-Reported Health & Insurance
Regarding self-reported health, 88.6% (n = 356) of the Maadi population believed that
their health is ranked as good. In Shagret Mariam, 92.5% (n = 370) believed that health is
good. The difference of the reported health status between the two areas was significant
and it might be due to socioeconomic difference where the population in Maadi have
more resources and awareness of their health and access to healthcare evaluation more
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than those in Shagret Mariam with limited economic resources and awareness. In Maadi,
13.4% (n = 54) had a chronic illness compared to 7.5% (n = 30) in Shagret Mariam and
this significant difference might be also due to again the socioeconomic gap and access to
healthcare. Rates of diagnoses of chronic illness were higher in Maadi because of
resource availability and access to healthcare services unlike in Shagret Mariam where
participants did not have the same privilege. This difference could explain the gap in the
rates of chronic illnesses. The most common chronic disease in both areas was high blood
pressure, followed by diabetes, and heart diseases. The rates of chronic diseases were
significantly higher (double) in Maadi than in Shagret Mariam which was expected to be
the opposite, however, this might be again due to having access to healthcare and
accordingly having proper diagnosis. As Maadi is a high-income area with higher
socioeconomic status, population of Maadi have access to healthcare units and proper
medical diagnosis more than in Shagret Mariam.

Maadi’s population had four times the rate of health/medical insurance than in
Shagret Mariam where 51.2% (n = 206) of Maadi residents had health insurance
compared to only 12.5% (n = 50) in Shagret Mariam. The significant gap in having a
health insurance reflected the socioeconomic level difference between the two areas.
When running a correlation test, having health insurance was not significantly related to
SMA. This could be due to the fact that antibiotics are easily accessible with or without
health insurance plans and patients can get them from any pharmacy whether it is low or
high-income area. In the low-income area, where prevalence of SMA was four times
more likely than in the high-income, percentage of people with health insurance was only
12.5%. Therefore, even with low percentage of health insurance coverage in Shagret
Mariam, there was still high SMA prevalence indicating that health insurance did not
affect the SMA practice. These results were similar to the study in Jordan, where health
insurance and SMA showed insignificant relationship (Sawair et al., 2009). The full
100% coverage was provided to 24.6% (n = 51) of the population in Maadi compared to
12% (n = 6) only in Shagret Mariam reflecting the type of coverage the two populations
had. From these results, it seemed that even those in the low-income area of Shagret
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Mariam, having health insurance did not mean full coverage or access since more than
54% had only limited access of 50-70% in Shagret Mariam, yet in Maadi, the most
common coverage was full 100% coverage for 41.5% (n = 86). Regarding smoking, a
significant difference was found between the two areas where 34.3% (n = 138) of Maadi
were smokers compared to 23% (n = 92) in Shagret Mariam which was the opposite of
what was expected.

4.3 Prevalence of Antibiotic Use, SMA and Socioeconomic Level
Consumption of antibiotics among adult study participants was 24.1% (n = 97) in Maadi,
which was significantly higher than in Shagret Mariam 18% (n = 72). Consumption in
Maadi for participants who had given their children/care receiver was also higher in Maadi
67.2% (n = 205) than in Shagret Mariam 61.6% (n = 202) yet it was not a significant
difference. The total consumption rate per family/household in the high-income area of
Maadi was 75.1% (n = 302) which was significantly higher than in the low-income area of
Shagret Mariam where total consumption was 68.5% (n = 274). Each household in Maadi
consumed more antibiotics than in Shagret Mariam. The total consumption of antibiotics
means consumption by the adult who participated in the study or by his children/care
receiver in the household and the total consumption includes both prescribed antibiotics
(by physician) and self-medicated antibiotics. It was hypothesized that total
consumption/use of antibiotics would be higher in Shagret Maraim than in Maadi however,
the results showed the opposite. Reasons that might be contributing to the higher level of
consumption in Maadi than in Shagret Mariam is the wider access to healthcare resources
and physicians, having health insurance plans with more coverage and having higher
socioeconomic level explains affordability of antibiotics and also access to physician
prescriptions. In Shagret Mariam, 12.5% (n = 50) had health insurance plans compared to
51.2% (n = 206) in Maadi. Population in Shagret Mariam also had less salaries and lower
socioeconomic level to afford to visit a physician. Affordability was also shown as a factor
contributing to SMA because it is more affordable for low-income communities to practice
SMA than to visit a physician (Ocan et al., 2015).
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Although the consumption of antibiotics was significantly higher in Maadi than in
Shagret Mariam, the prevalence of self-medication SMA without prescription was almost
four times significantly higher (p value = 0.00) in Shagret Mariam than in Maadi. As one
of the main objectives of this study, the prevalence of SMA was estimated in both areas.
As illustrated in Table 2, SMA in Maadi was 12.9% (n = 39) which means that 12.9% in
Maadi of those who consumed antibiotics in the last six months practiced SMA compared
to 47.4% (n = 130) in Shagret Mariam. These results resonated with a similar study in
Beirut where antibiotic dispensing without prescription was higher in the lower socioeconomic areas than the higher-socioeconomic areas (Farah et al., 2015). This gap between
SMA in Maadi and Shagret Mariam can be associated with level of awareness about
antibiotics uses, not having health insurance plans which makes it hard for people to go see
a physician. These findings agreed with the hypothesis that higher rates of SMA are to be
found in the lower-socioeconomic areas with lower educational level and limited
healthcare services.

4.4 Reasons for SMA & the Socioeconomic Level
As illustrated in Table 3 above, the main reasons for SMA in the both low-income area of
Shagret Mariam and the high-income area of Maadi was participants’ previous experience
with similar symptoms or diseases which accounted for 89.2% (n = 116) in Shagret Mariam
and 79.5% (n = 31) in Maadi. Sawair et al., 2009 also found that patients’ past experience
with similar illness/symptoms was among the main reasons for SMA along with saving
time. Saving time came as the second reason for SMA but only in the high-income area of
Maadi 25.6% (n = 10) However, in the low-income area of Shagret Mariam the cost of
physician represented the second main reason for SMA with 50.8% (n = 66) of the
population. Cost of physicians was also indicated as a main reason for practicing SMA in
low-socio economic settings in Guatemala (Ramay et al., 2017) which is in concord with
the study findings. Interestingly cost of physician represented only in Maadi came as the
third reason and accounted for 5.1% (n = 2). A significant correlation was found between
the two selected areas (socioeconomic level) and SMA behavior (p=0.00) where higher
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rates of SMA without prescription was four times more likely in thelow-income area
(Shagret Mariam) than in the high-income area (Maadi). The two selected areas had
significant socioeconomic level differences and finding this correlation resembled findings
from previous studies showing that socioeconomic difference is correlated with SMA
behavior. In Lithuania, populations in rural areas consumed 1.79 times more antibiotics
without prescription than in urban areas (Berzanskyte et al., 2006). Poverty in LMICs is
correlated with self-medication behavior as indicated by Bloom et al., (2015) where
findings showed that it was more affordable to self-medicate rather than visit a physician
first as well as results from Ramay et al., 2017. In Beirut, 32% of antibiotics were dispensed
without prescription in low-income areas (Farah et al., 2015) and in Syria, people from low
and medium-incomes showed higher SMA rates (Barah & Gonçalves, 2010). The results
corresponded similarly with the findings of Hadi et al., 2016 in Saudi Arabia where an
inability to afford a consultation with a physician was the most common reason for
dispensing antibiotics without prescription representing 65.3%. In Tanzania, lack of
affordability was also contributing to self-medication with antimalaria due (Chipwaza et
al., 2014).

4.5 Perceived Symptoms for Antibiotics Consumption
As shown in Table 4, variety of symptoms that triggered participants to consume
antibiotics. In both low and high-income areas, some of the main symptoms were having
fever, common cold and sore throat respectively. In Maadi, fever represented 67.5% (n =
204), common cold was 62.6% (n = 189), sore throat was 54.6% (n = 165), and cough
respectively. In Shagret Mariam fever was 75.8% (n = 207), common cold was 61.2% (n
= 167), sore throat was 60.1% (n = 164) and cough was 53.8% (n = 147) respectively. In
Iran, common cold was also shown to be the main symptom for SMA with 48% of those
who self-medicated (Heidarifar et al., 2013). A viral infection often causes fever, yet it was
the most frequent symptom that causing participants to consume antibiotics (Llor &
Bjerrum, 2014). Consuming antibiotics for fever was reported before in Gulf countries as
the first treatment option people turn to when having fever (Aly & Balkhy, 2012).
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Respiratory infections whether bacterial or viral seem to be the main cause for the common
symptoms of fever, common cold, sore throat, and cough. However, fever was the most
common symptom. Common cold was also a symptom that majority of physicians (64%)
and pharmacists (81%) in Minya, Egypt prescribed antibiotics for (Dooling et al., 2014).
Data from the low and high-income areas conformed to data from Jordan where more than
60% of patients also took antibiotics to treat common cold (Shehadeh et al., 2012). Ear
ache, headache, and dental problems, 15.8% (n = 43), 7.3% (n = 20) and 5.9% (n = 16)
respectively, were also among the symptoms of those taking antibiotics but were not as
common. Additionally, In Shagret Mariam, diarrhea was 4.8% (n = 13), and cramping was
11.4% (n = 31).

4.6 Participants behavior for taking antibiotics
Understanding how participants consumed antibiotics in terms of frequency and the
duration in both areas were examined. In both low and high-income areas, majority of
participants who took antibiotics did use the drug as frequently as recommended. In the
high-income area, all those who consumed antibiotics in the last six months (n = 302)
stated that they took the dose of antibiotics as per the recommended frequency whether
by the advice of the physician or by the leaflet of the medication in case of SMA and
98.5% (n = 270) in the low-income area. Regarding adherence to the course of
antibiotics, surprisingly both populations had a greater than 90% adherence to the course
of antibiotics with no significant difference. Adhering to the course of antibiotics in both
areas might be associated with overuse behavior without knowledge about the dangers of
antibiotics. These results were the opposite of what was hypothesized before conducting
the study. A study in Minya, Egypt showed that some people preferred to take antibiotics
for prophylactic purposes whenever they need rather than the long course of treatment
(Kandeel et al., 2014). Fernandes et al., 2014 showed that non-adherence to antibiotics
was common in Lisbon with 57.7% prevalence.
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Part of this study was to assess the knowledge of participants about antibiotics role
in treating viruses and bacteria in the two areas. In the high-income area, 96.1% (n = 374)
stated that antibiotics treat both viruses and bacteria, only 1.5% (n = 6) said antibiotics do
not treat both viruses and bacteria, and 2.3% (n = 9) did not know if antibiotics treat viruses
and bacteria or not. In the low-income area 83.5% (n = 334) agreed that antibiotics treat
both viruses and bacteria and 1% (n = 4) stated that antibiotics do not and 15.5% (n = 65)
said they do not know. It was expected that more awareness about the use and role of
antibiotics in treating bacteria and viruses would be common in Maadi however results
showed there was little knowledge about the difference between viruses and bacteria and
what antibiotics can treat. Additionally, a large percent 15.5% of the population in the lowincome area stated that they do not know if antibiotics treat bacteria and viruses or not
compared to only 1.5% in Maadi who said the same. Little/no knowledge about antibiotics
role in treating bacterial and viral infection was common among the two populations. In
Egypt, Kandeel et al., 2014, revealed that parents (caregivers) preferred giving antibiotics
as a prevention for common cold (Kandeel et al., 2014) and in Jordan, 28.1% misused
antibiotics as pain killers, and 55.6% used them as preventive treatment (Shehadeh et al.,
2012). Similar findings from Lithuania showed that 26.0% of Lithuanians thought
antibiotics were effective against viral infections and 61% of them did not have the
knowledge about what antibiotics do (Pavydė et al., 2015). Yet, in Sweden, only 19.1%
who agreed that antibiotics cure common colds/ viral infection (André et al., 2010). These
findings reflect that the socioeconomic level of the population reflects the knowledge and
understanding of antibiotics as shown in this research and by Shehadeh et al., 2012.

Surprisingly, in the high-income area, 3.5% (n = 14) of participants said that went
to another physician when the first one did not prescribe them with antibiotics compared
to 2.5% (n = 10) who did the same in the low-income area. The reason might be contributed
to the fact that more people from the high-income area have already access to physicians
unlike the population in the low-income area where there is limited access. The population
in Maadi thus had the resources and affordability to visit more than one physician given
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the socioeconomic difference between the two areas and the fact that cost to visit physician
was one of the main reasons for SMA in the low-income area.

4.7 Types of Antibiotics Consumed
In the high-income area, 19.1% (n = 58) did not know which type of antibiotics they took
compared to 31.8% (n = 87) in the low-income area. However, the most used class of
antibiotics in both high and low-income areas was Amoxicillin, with 60.7% (n = 184) usage
in Maadi and 48.2% (n = 132) in Shagret Mariam. Amoxicillin was also the most used
antibiotic in Abu Dhabi with 46.3% (Abasaeed et al., 2009). Khalil et al., 2013 showed
also that Amoxicillin was the most used antibiotics by Saudi patients (86.6%) for dental
problems. These results agreed with the findings of Elhassan et al., 2016 whose findings
showed that Amoxicillin was among the generic affordable antibiotics available.
Amoxicillin was the most consumed antibiotics for self-medication in Greece (Skliros et
al., 2010). The second most commonly consumed antibiotic was different in the two areas,
where in the high-income part, Penicillin 8.9% (n = 27) ranked second and in the lowincome area, it was Cefotaxime 8.4% (n = 23).

4.8 Education and SMA
A significant correlation was found between educational level and SMA in the lowincome area, indicating that with a lower educational level, there is a higher SMA
behavior. These results conformed with studies by (Awad & Aboud, 2015; Barah &
Gonçalves, 2010; & Jose et al., 2013) in which educational level was significantly related
to SMA in Kuwait, Syria, and Oman respectively. Alhomoud et al., (2017) has also
showed that lower levels of education were correlated with an increase in prevalence of
SMA. SMA in Haiti was significantly lower among patients who had a university degree
compared to those who were illiterate (Moise et al., 2017). However, data in the highincome area in Maadi did not show a significant correlation between educational level
and SMA. These results might be due to the fact that SMA prevalence was relatively low
in Maadi compared to Shagret Mariam and therefore educational background did not
show a significant correlation. These results between education and SMA in the high70

income area relates to the findings in Abu Dhabi, Sudan and Alexandria, Egypt, where
the rates of SMA were higher among those with higher educational level (Abasaeed et al.,
2009; Awad et al., 2005; Sallam et al., 2009).

4.9 Determinants of SMA
When running three logistical regression models and accounting for different factors,
education showed one fixed determinant that is significantly contributing to SMA.
Income also is another factor however when adding income to the same model that has
residency, it did not show any significance. Income and residency seems to affect each
other which indicated that they both represent the same factor (socioeconomic
difference). These results reflect that SMA’s determinants are education, and income
(socioeconomic level).

Limitations and Drawbacks
One of the challenges of the study was finding a suitable questionnaire that has been used
and validated before. Contacts have been made with researchers in Lithuania, Lebanon,
UK, and Egypt and some of them answered back. All these studies had similar objectives
which is to assess the status and prevalence of SMA. The most time-consuming step was
also finding the criteria for selecting low and high-income areas. Examination of
government and national publications on socioeconomic categorization of areas in Egypt
was not easy to find. Cairo has many informal settlements with different criteria so
identifying only low and high-income area was a challenge. Finding the work of Dr.
Khadr has helped significantly in overcoming this issue.

Another difficulty was the low response rate in the high-income area of Maadi.
Finding and recruiting participants for the study in Maadi took a longer time than in
Shagret Mariam with three more days of field work. Some of the questions in the
questionnaire could have been asked differently or skipped. One of the questions was
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employment which had five choices as adopted from the original questionnaire however,
if it would have been asked with only two choices “working/not working” would have
been more efficient since there was no need for all the other categories of non-working.
“Did you stick to the duration and frequency of antibiotics?” might have been confusing
to explain the difference between frequency and duration of the course of antibiotics.
Another question that could have been simpler was “Do antibiotics treat viruses and
bacteria?” this question could have been divided into two questions, one about antibiotics
treating bacteria and another one if antibiotics treat viruses so not to confuse participants
especially given the high response that antibiotics treat both bacteria and viruses. The
question on the number of children might have been extra that was not needed. Another
one was the questions on diarrhea, constipation, and ulcer, they were not specific and
were a repetition to question #23 where a list of perceived symptoms was provided and
included gastrointestinal symptoms. The income question was put as a range so that
participants would respond honestly however, it would have been more useful to have the
salary as a number (continuous variable) for the statistical analysis on SPSS later.

Some of the challenges also were finding the pharmacies as per the criteria; nonchain pharmacy, located within the selected area on the map and getting owners’ consent.
Maadi especially as a high-income area had more chain pharmacies than non-chain. In
Shagret Mariam, non-chain pharmacies were more common than chain-ones. When
entering the data manually, numbers and codes should have been the only information
entered, however some wording was also added to the excel sheet. After thorough review
for few days, the data was re-organized into codes and numbers and the words were
replaced with the codes. Study was conducted in the month of September which might
affect the rate of consumption of antibiotics. In the winter, common cold and flu are
common and so is the consumption of antibiotics and in the summer, heat also
contributes to increasing some infection disease especially gastrointestinal (Lin et al.,
2016) and therefore, the time when the study was conducted might be a factor.
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Conclusion & Recommendation
As per the findings of this study, prevalence of SMA was found to be four times higher in
the low-income area compared to the high-income area reflecting the significance of the
socioeconomic level and education level affecting the prevalence of SMA. However,
consumption of antibiotics per family was significantly higher in the high-income area
more than in the low-income area. Reasons for SMA were having previous experience
with the disease/symptoms yet cost of physician was the second main reason in the lowincome setting compared to saving time as the second reason in the high-income setting.
Lack of knowledge about antibiotics effectiveness in treating bacterial and viral
infections was found to be common in both high and low-income areas. The most
common used antibiotic was Amoxicillin.

As observed in this study, SMA prevalence was high especially in low-income
settings due to the socioeconomic difference reflected in the two areas selected; Maadi
and Shagret Mariam. The prevalence of SMA was higher in low-income areas reflecting
that it is a contributing factor. A follow up study to examine the SMA behavior with
AMR prevalence in the population of both areas; high and low-income, would validate
the relationship between SMA and development of resistance. Such a study would
include behavioral and clinical assessment. From the findings, limited access to physician
due to the cost and lack of health insurance coverage is a factor contributing to SMA
behavior. Thus, facilitating access to affordable healthcare especially in low-income
settings would hopefully decrease the prevalence of SMA in poorer areas. The SMA
behavior is complex and many factors are involved. Another important recommendation
is educating the public about the long-term dangers of antibiotics on a national scale
which can be successful such as Egypt’s campaign on vaccination. From a legal
perspective, understanding the regulatory framework of antibiotic dispensing in Egypt
would be another study to better recommend and enforce regulations that would limit
SMA. It would be also useful to conduct the same study over a year-long to put into
account the seasonal variations and the rate of antibiotic consumptions. Further research
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should be done also to assess the rate of prescription by physicians and pharmacists
which would provide a different perspective on the issue. Since physicians and
pharmacists also prescribe unnecessary antibiotics sometimes with no proper
appropriateness.
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APPENDIX A
Questionnaire from Sawair et al., 2009

Please answer the following questions:
1.

Age ……… (years)

2.

Gender:

3.

Marital status:

4.

Level of education:

M

F
Single

Married

Divorced

Widowed

- No formal education

- Primary School

- Secondary school

- High School

- University degree

- Postgraduate

-Working

-Retired

-Unemployed

-Housewife

-Student

5.

6.

Employment situation:

Household monthly income:

- < 100 JDs

- 100-200 JDs

- 200-300 JDs

- 300-400 JDs

- 400-500 JDs

- > 500 JDs

- Intermediate

- Poor

7.

Self-reported health:

- Good
8.

Chronic Morbidity:

- Yes
9.

- No

Disease/s; ----------------------------

Medical Insurance:

- Yes (100% covered)

- Yes (80-90% covered)

- Yes (50-70% covered)

- No
10.
- Yes

Smoking:
- No

- Ex-smoker

11. Had you taken antibiotics in the last 6 months without consulting a physician?
- Yes

- No
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12. If yes, please specify why you had taken the antibiotics the last time?


Common cold



Cough



Fever



Sore throat



Earache



Painful urination



Abdominal pain



Diarrhea



Toothache (dental Infections)



Rash, dermatological problems



Headache



Others, please

specify:_____________________________________________________
13.

The source of the antibiotic:



Directly from private pharmacy



Relatives and friends



Left over drugs from previous treatment

14.

Which antibiotic you had taken:



Penicillin



Amoxicillin



Metronidazole



Cephalosporins



Erythromycin



Clindamycin



Lincomycin



Others, _______________________________________________________

15.

Dose, frequency and duration of the antibiotic taken compared to recommended

guidelines:


Correct



Incorrect
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16.

Reasons for self-medication:



Cost, because of no insurance



Easier and less time consuming



Previous experience with similar illness



Hate visiting doctors



No doctors nearby



Others, _______________________________________________________

17.

Had you ever gone to another physician to obtain antibiotics when the first

physician you saw did not prescribe antibiotics?
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Yes

No

APPENDIX B
Questionnaire in Arabic

رقم االستمارة:

إستمارة
موافقة مسبقة للمشاركة في دراسة بحثية

عنوان البحث  :أﺳبﺎب إﺳﺘخﺪﺍم ﺍﻟﻤضﺎﺩﺍت ﺍﻟﺤﻴﻮيﺔ في ﺍﻟقﺎهرة
الباحث الرئيسي :شﻴﻤﺎء ﻣﺤﻤﺪ حسن  -الهاتف:

 - 01221879619البريد االلكترونيshyma2a@aucegypt.edu :

السرية واحترام الخصوصية :ﺳﺘكﻮن هﻮيﺘك ﺳريﺔ - .ﺍن ﺍﻟﻤشﺎركﺔ فى هذه ﺍﻟﺪرﺍﺳﺔ ﻣﺎهى ﺍال ﻋﻤل تطﻮﻋى ,حﻴث أن
ﺍالﻣﺘﻨﺎع ﻋن ﺍﻟﻤشﺎركﺔ اليﺘضﻤن أى ﻋقﻮبﺎت أو فقﺪﺍن أى ﻣزﺍيﺎ تﺤق ﻟك .ويﻤكﻨك أيضﺎ ﺍﻟﺘﻮقف ﻋن ﺍﻟﻤشﺎركﺔ فى أى وقت ﻣن ﺩون
ﻋقﻮبﺔ أو فقﺪﺍن ﻟهذه ﺍﻟﻤزﺍيﺎ .ال يﻮجﺪ أي ﻣخﺎطر وال يﻮجﺪ إﺳﺘفﺎﺩة ﻣﺘﻮقﻌﺔ ﻣن ﺍﻟﻤشﺎركﺔ بهذﺍ ﺍﻟبﺤث.

ﻣﻠﺤﻮظﺔ :ﺍﻟﻤطهرﺍت ﺍﻟﻤﻌﻮيﺔ ﻣثل( ﺍألنﺘﻴﻨﺎل وفالجﻴل و ضﻴﺎكﺲ وأﻣريزول و ﺳﻴبروﺩيﺎزول) يﻌﺘبروﺍ ﻣضﺎﺩﺍت حﻴﻮيﺔ

م

األسئلة ومحدداتها

1

ﻣﺤل ﺍإلقﺎﻣﺔ

2

ﺍﻟﻌﻤر بﺎﻟسﻨﻮﺍت ﺍﻟكﺎﻣﻠﺔ؟

3

نﻮع ﺍﻟﻤسﺘﺠﻴب؟

4

ﺍﻟﺤﺎﻟﺔ ﺍالجﺘﻤﺎﻋﻴﺔ

5

هل ﻟﺪيك ﺍطفﺎل

6

ﻋﺪﺩ ﺍالطفﺎل؟

انتقل
إلي

الكود الخاص باإلجابة

ﺍﻟﻌﻤر بﺎﻟسﻨﻮﺍت ﺍﻟكﺎﻣﻠﺔ [___|___] ......... ................................
ذكر ............. ................................ ................................
ﺍنثى ............. ................................ ................................
أﻋزب  /ﻋﺎزبﺔ ................................ ................................
ﻣﺘزوج/ﻣﺘزوجﺔ ............................... ................................
ﻣطﻠق/ﻣطﻠقﺔ .................................... ................................
أرﻣل/ﺍرﻣﻠﺔ .................................... ................................
نﻌم ............... ................................ ................................
ال ................. ................................ ................................
ﻋﺪﺩ ﺍالطفﺎل [___|___] ..................... ................................

1
2
1
2
3
4
1
2

7

ﻣسﺘﻮى ﺍﻟﺘﻌﻠﻴم

ال يﻮجﺪ تﻌﻠﻴم رﺳﻤي ......................... ................................
شهﺎﺩة ﺍبﺘﺪﺍئﻴﺔ ................................... ................................
شهﺎﺩة ﺍﻋﺪﺍﺩيﺔ .................................. ................................
شهﺎﺩة ثﺎنﻮيﺔ .................................... ................................
شهﺎﺩة جﺎﻣﻌﻴﺔ ................................... ................................
ﺩرﺍﺳﺎت ﻋﻠﻴﺎ .................................... ................................

1
2
3
4
5
6

8

ﺍﻟﺤﺎﻟﺔ ﺍﻟﻮظﻴفﻴﺔ

يﻌﻤل ............ ................................ ................................
ﻣﺘقﺎﻋﺪ .......... ................................ ................................
ﻋﺎطل ﻋن ﺍﻟﻌﻤل .............................. ................................
ربﺔ ﻣﻨزل ...................................... ................................
طﺎﻟب  /طﺎﻟبﺔ .................................. ................................

1
2
3
4
5

9

ﻣﺎ هي وظﻴفﺘك؟

10

ﺍﻟﺪخل ﺍﻟشهري ﻟالﺳرة (بﺎﻟﺠﻨﻴه ﺍﻟﻤﺼري)؟

ﺍقل ﻣن ................................. ................................ 1500

95

1

7

10
10
10
10

األسئلة ومحدداتها

م

11

كﻴف ترى حﺎﻟﺘك ﺍﻟﺼﺤﻴﺔ

12

هل ﻟﺪيك أي ﻣشكﻠﺔ صﺤﻴﺔ ﻣزﻣﻨﺔ؟ زي
ﺍﻟسكر أو غﺪة /قﻠب/
كﻮﻟﻴسﺘﻴرول
ﻣﺎ هي ﻣشكﻠﺔﺍﻟﺼﺤﻴﺔ /ﺍﻟﻤرض ﺍﻟﻤزﻣن؟

14

هل ﻟﺪيك تأﻣﻴن صﺤي؟

15

ﻣﺎ هﻮ نﻮع تغطﻴﺔ ﺍﻟﺘأﻣﻴن ﺍﻟﺼﺤي ﺍﻟﺘي
ﻟﺪيك؟

16

هل تﺪخن:

17

هل أخﺪت (تﻨﺎوﻟت) أي ﻣضﺎﺩﺍت حﻴﻮيﺔ
خالل ﺍﻟسﺘﺔ أشهر
ﺍﻟﻤﺎضﻴﺔ؟
هل أخﺪ أحﺪ أطفﺎﻟك أو أحﺪ أفرﺍﺩ أﺳرتك
ﻣضﺎﺩﺍت حﻴﻮيﺔ خالل
ﺍﻟسﺘﺔ أشهر ﺍﻟﻤﺎضﻴﺔ؟
إذﺍ كﺎنت ﺍإلجﺎبﺔ بﻨﻌم ألطفﺎﻟك  /أو أحﺪ
أفرﺍﺩ أﺳرتك؟ كم ﻋﻤره /ﻋﻤرهﺎ؟
ﺍنت ﺍﻟﻠي قررت تأخﺪ ﺍﻟﻤضﺎﺩ ﺍﻟﺤﻴﻮي
بﻨفسك؟ ﻣن غﻴر روشﺘﺔ؟
(أو تﻌطي ﺍﻟﻤضﺎﺩ ﺍﻟﺤﻴﻮي ألطفﺎﻟك أو
أحﺪ أفرﺍﺩ أﺳرتك)

21

13

18

19
20

انتقل
إلي

الكود الخاص باإلجابة
................................ ................................ 4000 - 1500
................................ ................................ 6000 - 4001
................................ ................................ 8000 - 6001
.............................. ................................ 10000 - 8001
............................ ................................ 12000 - 10001
أكثر ﻣن ............................. ................................ 12000

2
3
4
5
6
7

جﻴﺪة ............. ................................ ................................
ﻣﺘﻮﺳطﺔ ......................................... ................................
ضﻌﻴفﺔ ........... ................................ ................................

1
2
3
1

ال ................. ................................ ................................

2

نﻌم .............. ................................ ................................

نﻌم .............. ................................ ................................
ال ................. ................................ ................................
تغطﻴﺔ شﺎﻣﻠﺔ ...................... ................................ 100%

1
2
1

تغطﻴﺔ ........................... ................................ %90-80
تغطﻴﺔ ............................ ................................ %70-50
أقل ﻣن ................................ ................................ % 50
ال أﻋرف ...................................... ................................
نﻌم .............. ................................ ................................
ال ................. ................................ ................................
ﻣﺪخن ﺳﺎبق .................................... ................................

2
3
4
5
1
2
3
1

ال ................. ................................ ................................

2
1

ال ................. ................................ ................................
ﺍﻟﻌﻤر بﺎﻟسﻨﻮﺍت [___|___] ................ ................................

2

نﻌم .............. ................................ ................................

نﻌم .............. ................................ ................................

نﻌم .............. ................................ ................................

1

ال ................. ................................ ................................

2

أﺳبﺎب شرﺍء ﺍﻟﻤضﺎﺩ ﺍﻟﺤﻴﻮي ﻣن غﻴر
روشﺘﺔ؟ ﻟﻴه ﺍخذته ﻣن نفسك؟

تكﻠفﺔ ﺍﻟﺪكﺘﻮر ................................... ................................

1

(ليه اخدته من نفسك)

بسبب ﻋﺪم وجﻮﺩ تأﻣﻴن صﺤي ............... ................................

2
3
4
5
6

أﺳبﺎب أخرى ................................ ................................
ﺍﻟﺪكﺘﻮر ﺍﻟﻤﻌﺎﻟج .............................. ................................

7
1

بﻨﺼﻴﺤﺔ ﺍﻟﺼﻴﺪﻟي ............................ ................................

2
3
ال

أقل ﺍﺳﺘهالكﺎ ﻟﻠﻮقت ﻣن زيﺎرة ﺍﻟﺪكﺘﻮر ................................
تﺠربﺔ ﺳﺎبقﺔ ﻣع ﺍﻟﻤرض /أﻋرﺍض ﻣﻤﺎثﻠﺔ ............................
كرﺍهﻴﺔ زيﺎرة ﺍألطبﺎء ...................... ................................
ال يﻮجﺪ أطبﺎء قريبﻴن أو وحﺪة صﺤﻴﺔ قريبﺔ .........................

22

ﻣﻴن ﺍﻟﻠي كﺘبﻠك ﺍﻟﻤضﺎﺩ ﺍﻟﺤﻴﻮي؟ ﺍو قﺎﻟك
تﺎخﺪه

23

ﻣن فضﻠك ﺍذكر أي ﻣن ﺍألﻋرﺍض
ﺍﻟﺘﺎﻟﻴﺔجﻌﻠﺘك أنت أو أطفﺎﻟك أو

بﻨﺼﻴﺤﺔ ﻣن ﺍألقﺎرب وﺍألصﺪقﺎء ...............................
نﻌم

96

14

16

20

26

22

األسئلة ومحدداتها

م

أحﺪ أفرﺍﺩ أﺳرتك ﺍﻟﺘي تﻌﺘﻨي به ،تأخذ
ﺍﻟﻤضﺎﺩﺍت ﺍﻟﺤﻴﻮيﺔ في ﺍل 6
شهﻮر ﺍﻟﻤﺎضﻴﺔ؟
)الجواب يمكن أن يتضمن أكثر من
أعراض(
سؤال متعدد

انتقل
إلي

الكود الخاص باإلجابة

........................................................................ .Aنزالت
ﺍﻟبرﺩ .............................................................................
..........................................................................Bﺍﻟسﻌﺎل
 /ﺍﻟكﺤﺔ .........................................................................
..........................................................................Cحﻤى
........................................................................ .Dﺍﻟﺘهﺎب
ﺍﻟﺤﻠق ...........................................................................
......................................................................... .Eصﺪﺍع
......................................................................... .Fوجع
ﺍألذن ...........................................................................
........................................................................ .Gآالم
أثﻨﺎء ﺍﻟﺘبﻮل ....................................................................
........................................................................ .Hﺍألﺳﻨﺎن
(ﺍﻟﺘهﺎبﺎت ﺍألﺳﻨﺎن) ..........................................................
.......................................................................... .Iﻣشﺎكل
في ﺍﻟﻌﻴن .......................................................................
...........................................................................Jطفح
جﻠﺪي ،ﻣشﺎكل جﻠﺪيﺔ .......................................................
........................................................................ .Kﺍإلﺳهﺎل

1

2

1

2

1

2

1

2

1
1

2
2

1

2

1

2

1

2

1

2

1

2

1
1

2
2

1

2

1
1

2
2

1

2

1
1

2
2

...................................................................................

......................................................................... .Lﺍﻣسﺎك
........................................................................ .Mﻣغص /
وجع بطن ......................................................................
........................................................................ .Nﺩم في
ﺍﻟبرﺍز ...........................................................................
........................................................................ .Oﺍنﺘفﺎخ
 ......................................................................... .Pغثﻴﺎن /
ﺍﻟشﻌﻮر بﺎﻟقيء ................................................................
........................................................................ .Qأﻟم
شرجي ..........................................................................
..........................................................................Rجفﺎف
......................................................................... .Sأﻋرﺍض
أخرى ،يرجى ﺍﻟﺘﺤﺪيﺪ.................................................... :
24

هل أنت (أوأطفﺎﻟك) أخذت جرﻋﺔ ﺍﻟﻤضﺎﺩ
ﺍﻟﺤﻴﻮي زي ﻣﺎ هﻴﺎ
ﻣكﺘﻮبﺔ في ﺍﻟﻨشرة ﺍو تﻌﻠﻴﻤﺎت ﺍﻟﺪكﺘﻮر
(ﻣثال ﻣرة كل  8ﺳﺎﻋﺎت) وال ﻣش بﺎﻟﻈبﻂ
(ﻋن طريق تﻮصﻴﺔ ﺍﻟﺼﻴﺪﻟي أو ﺍﻟطبﻴب
أو نشرة ﺍﻟﺪوﺍء)؟
هل أنت (أو أطفﺎﻟك) ﺍﻟﺘزﻣت بﻤﺪة ووقت
ﺍﻟﻤضﺎﺩ ﺍﻟﺤﻴﻮي زي ﻣﺎ ﻣكﺘﻮبﺎﻟك
(ﻣثال خﻠﺼت ﺍالﺳبﻮع كﻠه وال ﻟﻤﺎ
ﺍتﺤسﻨت بطﻠت بﺪري)
هل بﺘﻌﺎﻟج ﺍﻟﻤضﺎﺩﺍت ﺍﻟﺤﻴﻮيﺔ ﺍﻟفﻴروﺳﺎت
وﺍﻟبكﺘﻴريﺎ ؟

27

هل ذهبت إﻟى طبﻴب آخر ﻟﻠﺤﺼﻮل ﻋﻠى
ﺍﻟﻤضﺎﺩﺍت ﺍﻟﺤﻴﻮيﺔ ﻋﻨﺪﻣﺎ رفض أول
طبﻴب أن يﺼف ﺍﻟﻤضﺎﺩﺍت ﺍﻟﺤﻴﻮيﺔ؟

25

26

نﻌم ............... ................................ ................................
ال ................. ................................ ................................

نﻌم ............... ................................ ................................

1
2

1

ال ................. ................................ ................................

2

نﻌم ................................................................
ال .................................................................
ال أﻋرف ............................................................

1
2
3

نﻌم ...............................................................
ال ................................................................

1
2
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األسئلة ومحدداتها

م

انتقل
إلي

الكود الخاص باإلجابة

28

هل أخذت (أو أطفﺎﻟك أو أحﺪ أفرﺍﺩ
ﺍﺳرتك) ﺩوﺍء ﻟإلﺳهﺎل في ﺍألشهر ﺍل 3
ﺍﻟﻤﺎضﻴﺔ؟

نﻌم ... ............ ................................ ................................
ال …………………………………………………………....

1
2

29

هل أخذت (أو أطفﺎﻟك أو أحﺪ أفرﺍﺩ
ﺍﺳرتك) ﺩوﺍء ﻟإلﻣسﺎك في ﺍألشهر ﺍل 3
ﺍﻟﻤﺎضﻴﺔ؟

نﻌم .................. ................................ ................................
ال …………………………………………………………...

1
2

30

هل كﺎن ﻋﻨﺪك (أو ﻋﻨﺪ أطفﺎﻟك أو أحﺪ
أفرﺍﺩ ﺍﺳرتك) قرحﺔ بﺎﻟﻤﻌﺪة
أو ﺍإلثﻨي ﻋشر ﻣن قبل؟

نﻌم ............... ................................ ................................

1

ال ................. ................................ ................................

2

31

أي ﻣضﺎﺩﺍت ﺍﻟﺤﻴﻮيﺔ أخذتهﺎ أنت (أو أطفﺎﻟك أو أحﺪ أفرﺍﺩ أﺳرتك ﺍﻟﺘي تﻌﺘﻨي به):
1
يأخذ
ال يأخذ
ﺍﻟكﻮﺩ

0
1
1
1
2
2
2
2
2
2
1+2

3
3
3
4
4
5
5
5
6
6
6
7
7
7
7
8
8

ﺍالﺳم ﺍﻟﻌﻠﻤي

بﻨسﻠﻴن
بﻨسﻠﻴن
ﺍﻟبﻨسﻠﻴن  +ﺳﻮﻟبﺎكﺘﺎم
أﻣﻮكسﻴﻴﻠﻴن +
كالفﻮالنﺎت
أﻣﻮكسﻴﻴﻠﻴن +
كالفﻮالنﺎت
أﻣﻮكسﻴﻴﻠﻴن +
كالفﻮالنﺎت
أﻣﻮكسﻴﻴﻠﻴن  +حﻤض
كالفﻮالنﻴك
أﻣﻮكسﻴﻴﻠﻴن
أﻣﻮكسﻴﻴﻠﻴن
أﻣﻮكسﻴﻴﻠﻴن +
فﻠكﻠﻮكسﺎﺳﻴﻠﻴن
(بﻨسﻠﻴن)
ﻣﻴﺘرونﻴﺪﺍزول
ﻣﻴﺘرونﻴﺪﺍزول
ﺳﻴبروفﻠﻮكسﺎﺳﻴن /
ﻣﻴﺘرونﻴﺪﺍزول
نﻴفروكسﺎزيﺪ
نﻴفروكسﺎزيﺪ
ﺳﻴبروفﻠﻮكسﺎﺳﻴن
ﺳﻴبروفﻠﻮكسﺎﺳﻴن
ﺳﻴبروفﻠﻮكسﺎﺳﻴن
أزيثروﻣﻴسﻴن
أزيثروﻣﻴسﻴن
أزيثروﻣﻴسﻴن
كﻠﻴﻨﺪﺍﻣﺎيسﻴن
كﻠﻴﻨﺪﺍﻣﺎيسﻴن
كﻠﻴﻨﺪﺍﻣﺎيسﻴن
ﻟﻴﻨكﻮﻣﺎيسﻴن
ﺍألﺳﻴكﻠﻮفﻴر (ﻣضﺎﺩ
ﻟﻠفﻴروﺳﺎت)
ﺍألﺳﻴكﻠﻮفﻴر (ﻣضﺎﺩ
ﻟﻠفﻴروﺳﺎت)

ﺍالﺳم ﺍﻟﺘﺠﺎري

ال أﻋرف
ريﺘﺎربن حقن
بﻨسﻴﺘﺎرﺩ حقن
يﻮنﺎﺳن
ﺍوجﻤﻨﺘﻴن
هﺎيبﻴﻮتﻴك

0
1
2
3
4
5

ﻣﻴﺠﺎﻣﻮكﺲ

6

كﻴﻮرﺍم

7

أﻣﻮكسﻴل  500ﻣﻠﻴﺠرﺍم  /شرﺍب
بﻴﻮﻣﻮكﺲ  500ﻣﻠﻴﺠرﺍم  /شرﺍب
فﻠﻮﻣﻮكﺲ

8
9
10

فالجﻴل 500أو 250ﻣﻠﻴﺠرﺍم  /شرﺍب
أﻣريزول 500أو 250ﻣﻠﻴﺠرﺍم  /شرﺍب
ﺳﻴبروﺩيﺎزول
أنﺘﻴﻨﺎل
ضﻴﺎكﺲ
ﺳﻴبرو  500ﻣﻠﻴﺠرﺍم
ﺳﻴبروبﺎي
ﺳﻴبروفﺎر
زيثروﻣﺎكﺲ  250ﻣﻠﻴﺠرﺍم  /شرﺍب
زيثرون  500ﻣﻠﻴﺠرﺍم
زيثروكﺎن  500ﻣﻠﻴﺠرﺍم
ﺩالﺳﻴن
كالﺳﻴﺪ 500أو 250ﻣﻠﻴﺠرﺍم  /شرﺍب
كالريﻤﺎكﺲ 500أو 250ﻣﻠﻴﺠرﺍم
ﻟﻴﻨكﻮﺳﻴن 600أو 300ﻣﻠﻴﺠرﺍم
ﺍألﺳﻴكﻠﻮفﻴر
زوفﺎريكﺲ

11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
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2

م

األسئلة ومحدداتها

8
9
9
10
10
11
11
11
12
12
13
13
14
14
15

ﺍألﺳﻴكﻠﻮفﻴر (ﻣضﺎﺩ
ﻟﻠفﻴروﺳﺎت)
ﺳﻴفﺎﻟﻮﺳبﻮرين
ﺳﻴفﺎﻟﻮﺳبﻮرين
ﺳﻴفﻮتكسﻴم
ﺳﻴفﺘريﺎكسﻮن
كﻴﻨﻮﻟﻮن
كﻴﻨﻮﻟﻮن
كﻴﻨﻮﻟﻮن
فﻠﻮرو كﻴﻨﻮﻟﻮن
فﻠﻮرو كﻴﻨﻮﻟﻮن
تﺘرﺍﺳﻴكﻠﻴن
تﺘرﺍﺳﻴكﻠﻴن
أﻣﻴﻨﻮغﻠﻴكﻮﺳﻴﺪ
أﻣﻴﻨﻮغﻠﻴكﻮﺳﻴﺪ
كﻮتريﻤﻮكسﺎزول
أخري

الكود الخاص باإلجابة

ﻟﻮفﻴر

28

كﻴفﻠﻴكﺲ
ﺳﻴفي بﻴم
ﺳﻴفﻮتكﺲ
ﺳﻴفﺘريﺎكسﻮن
أوفﻠﻮكسﺎﺳﻴن
ﻟﻴفﻮفﻠﻮكسﺎﺳﻴن
ﺳﻴبروفﻠﻮكسﺎﺳﻴن
فﻠﻮكسﻴن
ﻟﻴفﺎكﻴﻮن
تﺘرﺍﺳﻴكﻠﻴن
ﺩوكسي ﺳﻴكﻠﻴن (فﻴبرﺍﻣﻴسﻴن)
جﻨﺘﺎﻣﻴسﻴن (جﺎرﺍﻣﻴسﻴن)
تﻮبرﺍﻣﻴسﻴن (تﻮبريكﺲ)
ﺳﻴبﺘرين
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29
30
31
32
33
34
35
36
37
38
39
40
41
42

انتقل
إلي

APPENDIX C
Questionnaire in English

Reasons for Antibiotics use in Cairo
18. Place of residency
19. Age ……… (years)
20. Gender:

M

21. Marital status:

F
Single

Married

Divorced

Widowed

22. If married, do you had any children?
- Yes

- No

23. Number of children
24. Level of education:
- No formal education

- Primary School

- Secondary school

- High School

- University degree

- Postgraduate

-Working

-Retired

-Unemployed

-Housewife

-Student

25.

Employment situation:

26. What is your job?

27. Household monthly income (EGP):
- < 1500

- <4000

- 4000 - 6000

- 6000 - 8000

- 8000 – 10,000

- 10,000 – 12,000

- Intermediate

- Poor

- > 12,000
28. Self-reported health:
- Good

29. Chronic Morbidity: (Do you had any longstanding illness or health problem?)
100

- Yes
30.

- No
If yes, what is the illness/ health problem?

31. Do you had health insurance?
- Yes

- No

32. What is the type of health insurance coverage do you had?
- 100% covered

- 80-90% covered

- Less than 50%

- I do not know

- 50-70% covered

33. Smoking:
- Yes

- No

- Ex-smoker

34. Had you taken any antibiotics in the last 6 months?
- Yes

- No

35. Had any of your children or a family member that you take care of, took antibiotics
in the last 6 month?
- Yes

- No

36. If yes for your children or a family member that you take care of? How old is
he/she? ……… (years)

37. Did you decide to take the antibiotics by yourself with no prescription?
-

Yes

- No

38. What are the reasons for self-medicating? Buying antibiotics without prescription?
-

Cost of physician

-

Because of no health insurance

-

Less time consuming than doctor’s visit

-

Previous experience with similar illness

-

Hate visiting doctors
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-

No doctors nearby or health units

-

Others, ________

39.

Who prescribed/told you to take the antibiotics?

-

The physician

-

With the advice of a pharmacist

-

With the advice of relatives or friends

40. Please specify why you (or your children or a family member that you take care of)
had taken antibiotics in the last 6 month? The answer can include more than one
symptoms
-

Common cold

-

Cough

-

Fever

-

Sore throat

-

Headache

-

Ear pain

-

Painful urination

-

Toothache (dental Infections)

-

Eye problems

-

Rash, dermatological problems

-

Diarrhoea

-

Constipation

-

Cramps / stomach ache

-

Blood in stool

-

Bloating

-

Nausea

-

Anal pain

-

Dehydration

-

Others, please

specify:_____________________________________________________
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41.

Did you (or your children or a family member that you take care of) take the

suggested dose of the antibiotics as recommended (Either by pharmacist, physician or
leaflet of the drug( ?
-

Yes

- No

42.

Did you (or your children or a family member that you take care of) stick to the

duration and frequency of the antibiotics as recommended (Either by pharmacist,
physician or leaflet of the drug?
43.

Do Antibiotics treat viruses and bacteria?

-

Yes

44.

Had you ever gone to another physician to obtain antibiotics when the first

- No

physician you saw did not prescribe antibiotics?
-

Yes

- No

45. Had you (or your children or a family member that you take care of) taken
laxatives in the last 3 months?
Yes
- No

46.

Had you (or your children or a family member that you take care of) taken

medicine for constipation in the last 3 month?
-

Yes

- No

47.
Had you (or your children or a family member that you take care of) ever had a
stomach (gastric) or duodenal ulcer?
-

Yes

48.

- No

Which antibiotic you (or your children or a family member that you take care of)

had taken:
Code

Generic Name

Brand Name

0

0
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1

Penicillin

Retarpen vial

1

1

Penicillin

Pencitard vial

2

1

Penicillin + Sulbactam

Unasyn

3

2

Amoxicillin + Clavulanate

Augmentin

4

2

Amoxicillin + Clavulanate

Hibiotic

5

2

Amoxicillin + Clavulanate

Megamox

6

2

Amoxycillin + Clavulanic acid

Curam

7

2

Amoxicillin

Amoxil 500 mg / Syrup

8

2

Amoxicillin

Biomox 500mg/ Syrup

9

Amoxicillin + Flucloxacillin

Flumox

10

Metronidazole

Flagyl 500/250 + Syrup

11

3

Metronidazole

Amrizole 500/250 + Syrup

12

3

Ciprofloxacin/ Metronidazole

Ciprodiazole

13

4

Nifuroxazide

Antinal

14

4

Nifuroxazide

Diax

15

5

Ciprofloxacin

Cipro 500 mg

16

5

Ciprofloxacin

Ciprobay

17

5

Ciprofloxacin

Ciprofar

18

6

Azithromycin

Zithromax 250 mg + Syrup

19

6

Azithromycin

Xithrone 500 mg

20

6

Azithromycin

Zithrokan 500 mg

21

7

Clindamycin

Klacid 500/250 mg + Syrup

22

1+2

(Penicillin)
3
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7

Clindamycin

Klarimax 500/250 mg

23

7

Clindamycin

Dalacin

24

7

Lincomycin

Lincocin 300/ 600 mg

25

8

Acyclovir (Antiviral)

Acyclovir

26

8

Acyclovir (Antiviral)

Zovarix

27

8

Acyclovir (Antiviral)

Lovir

28

9

Cephalosporins

Keflex

29

9

Cephalosporins

Cefepime

30

10

Cefotaxime

Cefotax

31

10

Ceftriaxone

Ceftriaxone

32

11

Quinolones

Ofloxacin

33

11

Quinolones

Levofloxacin

34

11

Quinolones

Ciprofloxacin

35

12

Fluoroquinolones

Floxin

36

12

Fluoroquinolones

Levaquin

37

13

Tetracyclines

Tetracycline

38

13

Tetracyclines

Doxycycline (Vibramycin)

39

14

Aminoglycosides

Gentamicin (Garamycin)

40

14

Aminoglycosides

Tobramycin (Tobrex)

41

15

Co-trimoxazole

Septrin

42

(Trimethoprim/sulfamethoxazole)
Others
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APPENDIX D
The consent form in Arabic

استمارة موافقة مسبقة للمشاركة في دراسة بحثية
عنوان البحث  :العوامل التي تؤثر علي العالج الذاتي بالمضادات الحيوية في القاهرة
الباحث الرئيسي :شيماء محمد حسن سليمان
البريد االلكترونيShyma2a@aucegypt.edu :
الهاتف01221879619 :
ﺍنت ﻣﺪﻋﻮ ﻟﻠﻤشﺎركﺔ فى ﺩرﺍﺳﺔ بﺤثﻴﺔ ﻋن ( العالج الذاتي بالمضادات الحيوية).
هدف الدراسة هﻮ
هو تحديد العوامل التي تؤثر علي العالج الذاتي بالمضادات الحيوية بمناطق مختلفة بالقاهرة.
-

ال يوجد أي مخاطر أو مضايقات من المشاركة بهذا البحث .فهو عمل تطوعي وكل البيانات سوف تكون مجهولة المصدر

-

ال يوجد إستفادة متوقعة من المشاركة بهذا البحث .و سوف يتم التخلص من البيانات بعد إنتهاء الدراسة.

السرية واحترام الخصوصية :ستكون هويتك سرية.

ان المشاركة فى هذه الدراسة ماهى اال عمل تطوعى ,حيث أن االمتناع عن المشاركة اليتضمن أى عقوبات أو فقدان أى مزايا تحق
لك .ويمكنك أيضا التوقف عن المشاركة فى أى وقت من دون عقوبة أو فقدان لهذه المزايا.
االمضاء.......................................................... :
اسم المشارك ................................................... :
التاريخ ............../................/......... :

ملحوظة :المطهرات المعوية مثل األنتينال وفالجيل و ضياكس يعتبروا مضادات حيوية
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APPENDIX E
Chi-Square test SMA with other variables

Crosstabs
Case Processing Summary
Cases
Valid
N
V20 Did you self-medicate with

Missing
Percent

576

N

71.8%

Total

Percent
226

N

28.2%

Percent
802

100.0%

antibiotics * V7 Level of
Education

V20 Did you self-medicate with antibiotics * V7 Level of Education Crosstabulation
Count
V7 Level of Education

V20 Did you self-medicate with
antibiotics

1 No formal

2 Primary

3 Preparatory

Education

Education

Education

1 Yes

34

70

65

169

2 No

20

116

271

407

54

186

336

576

Total
Chi-Square Tests
Value

df

Asymp. Sig. (2sided)

51.809a

2

.000

Likelihood Ratio

49.532

2

.000

Linear-by-Linear Association

51.164

1

.000

Pearson Chi-Square

N of Valid Cases

Total

576
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a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is
15.84.

Crosstabs
Case Processing Summary
Cases
Valid
N
V20 Did you self-medicate with

Missing
Percent

576

N

71.8%

Total

Percent
226

N

28.2%

Percent
802

100.0%

antibiotics * V1 Residency

V20 Did you self-medicate with antibiotics * V1 Residency Crosstabulation
Count
V1 Residency
1 Maadi

V20 Did you self-medicate with
antibiotics

Total

2 Shagret Mariam

1 Yes

39

130

169

2 No

263

144

407

302

274

576

Total

Chi-Square Tests
Value

df

Asymp. Sig. (2-

Exact Sig. (2-

Exact Sig. (1-

sided)

sided)

sided)

82.628a

1

.000

Continuity Correctionb

80.971

1

.000

Likelihood Ratio

85.640

1

.000

Pearson Chi-Square

Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases

.000
82.484

1

576
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.000

.000

a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 80.39.
b. Computed only for a 2x2 table

Crosstabs
Case Processing Summary
Cases
Valid
N
V20 Did you self-medicate with

Missing
Percent

576

N

71.8%

Total

Percent
226

N

28.2%

Percent
802

100.0%

antibiotics * V3 Gender

V20 Did you self-medicate with antibiotics * V3 Gender Crosstabulation
Count
V3 Gender
1 Male

V20 Did you self-medicate with
antibiotics

Total

2 Female

1 Yes

55

114

169

2 No

150

257

407

205

371

576

Total

Chi-Square Tests
Value

df

Asymp. Sig. (2-

Exact Sig. (2-

Exact Sig. (1-

sided)

sided)

sided)

.968a

1

.325

Continuity Correctionb

.789

1

.374

Likelihood Ratio

.976

1

.323

Pearson Chi-Square

Fisher's Exact Test

.341

Linear-by-Linear Association

.966

N of Valid Cases

576

1
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.326

.187

a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 60.15.
b. Computed only for a 2x2 table

Crosstabs
Case Processing Summary
Cases
Valid
N
V20 Did you self-medicate with

Missing
Percent

576

N

71.8%

Total

Percent
226

28.2%

antibiotics * V14 Medical
Insurance

V20 Did you self-medicate with antibiotics * V14 Medical
Insurance Crosstabulation
Count
V14 Medical

Total

Insurance
1 Yes
V20 Did you self-

2 No

1 Yes

36

133

169

2 No

178

229

407

214

362

576

medicate with
antibiotics
Total

Chi-Square Tests
Value

df

Asymp. Sig.

Exact Sig.

Exact Sig.

(2-sided)

(2-sided)

(1-sided)

25.737a

1

.000

Continuity Correctionb

24.785

1

.000

Likelihood Ratio

27.174

1

.000

Pearson Chi-Square

Fisher's Exact Test
Linear-by-Linear

.000
25.692

1

.000

Association

110

.000

N

Percent
802

100.0%

N of Valid Cases

576

a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 62.79.
b. Computed only for a 2x2 table

Crosstabs
Case Processing Summary
Cases
Valid
N
V20 Did you self-medicate with

Missing
Percent

576

N

Total

Percent

71.8%

226

N

28.2%

Percent
802

100.0%

antibiotics * V14 Medical
Insurance

V20 Did you self-medicate with antibiotics * V14 Medical Insurance
Crosstabulation
Count
V14 Medical Insurance
1 Yes

V20 Did you self-medicate with
antibiotics

Total

2 No

1 Yes

36

133

169

2 No

178

229

407

214

362

576

Total

Chi-Square Tests
Value

Pearson Chi-Square
Continuity Correctionb

df

Asymp. Sig. (2-

Exact Sig. (2-

Exact Sig. (1-

sided)

sided)

sided)

25.737a

1

.000

24.785

1

.000
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Likelihood Ratio

27.174

1

.000

Fisher's Exact Test

.000

Linear-by-Linear Association

25.692

N of Valid Cases

1

.000

.000

576

a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 62.79.
b. Computed only for a 2x2 table

Crosstabs
Case Processing Summary
Cases
Valid
N
V20 Did you self-medicate with

Missing
Percent

576

71.8%

N

Total

Percent
226

N

28.2%

Percent
802

100.0%

antibiotics * V8 Employment
status

V20 Did you self-medicate with antibiotics * V8 Employment status Crosstabulation
Count
V8 Employment status
1 Working

V20 Did you self-medicate with
antibiotics
Total

2 Retired

Total

3 Unemployed

1 Yes

78

14

77

169

2 No

216

45

146

407

294

59

223

576
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Chi-Square Tests
Value

df

Asymp. Sig. (2sided)

4.912a

2

.086

Likelihood Ratio

4.883

2

.087

Linear-by-Linear Association

3.726

1

.054

Pearson Chi-Square

N of Valid Cases

576

a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is
17.31.

Crosstabs
Case Processing Summary
Cases
Valid
N
V20 Did you self-medicate with

Missing
Percent

576

N

71.8%

Total

Percent
226

N

28.2%

Percent
802

100.0%

antibiotics * V4 Marital status

V20 Did you self-medicate with antibiotics * V4 Marital status Crosstabulation
Count
V4 Marital status
1 Single

2 Married

Total

3 Divorced

4 Widow

V20 Did you self-medicate with

1 Yes

21

133

11

4

169

antibiotics

2 No

45

344

4

14

407

66

477

15

18

576

Total

113

Chi-Square Tests
Value

df

Asymp. Sig. (2sided)

15.127a

3

.002

13.508

3

.004

Linear-by-Linear Association

.182

1

.670

N of Valid Cases

576

Pearson Chi-Square
Likelihood Ratio

a. 1 cells (12.5%) have expected count less than 5. The
minimum expected count is 4.40.
Case Processing Summary
Cases
Valid
N
V20 Did you self-

576

Missing

Percent
71.8%

N

Total

Percent

226

28.2%

N
802

Percent
100.0%

medicate with
antibiotics * V10
Household monthly
income

V20 Did you self-medicate with antibiotics * V10 Household monthly income Crosstabulation
Count
V10 Household monthly income
1 Less than 1500

Total

2 1500 - 4000

V20 Did you self-medicate with

1 Yes

132

37

169

antibiotics

2 No

155

252

407

287

289

576

Total

114

Chi-Square Tests
Value

df

Asymp. Sig. (2-

Exact Sig. (2-

Exact Sig. (1-

sided)

sided)

sided)

76.514a

1

.000

Continuity Correctionb

74.922

1

.000

Likelihood Ratio

79.981

1

.000

Pearson Chi-Square

Fisher's Exact Test
Linear-by-Linear Association

.000
76.381

N of Valid Cases

1

.000

.000

576

a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 84.21.
b. Computed only for a 2x2 table

Crosstabs
Case Processing Summary
Cases
Valid
N
V1 Residency * V7 Level of

Missing
Percent

N

Total

Percent

N

Percent

802

100.0%

0

0.0%

802

100.0%

802

100.0%

0

0.0%

802

100.0%

799

99.6%

3

0.4%

802

100.0%

802

100.0%

0

0.0%

802

100.0%

Education
V1 Residency * V8 Employment
status
V1 Residency * V10 Household
monthly income
V1 Residency * V16 Smoking
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V1 Residency * V7 Level of Education
Crosstab
Count
V7 Level of Education
1 No formal

2 Primary

3 Preparatory

4 High school

Education

Education

Education

Education

1 Maadi

0

0

4

76

2 Shagret Mariam

9

9

62

194

9

9

66

270

V1 Residency

Total

Crosstab
Count
V7 Level of Education
5 University Education

Total

6 Graduate Education

1 Maadi

298

24

402

2 Shagret Mariam

126

0

400

424

24

802

V1 Residency

Total

Chi-Square Tests
Value

df

Asymp. Sig. (2sided)

214.310a

5

.000

Likelihood Ratio

244.713

5

.000

Linear-by-Linear Association

191.709

1

.000

Pearson Chi-Square

N of Valid Cases

802
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a. 4 cells (33.3%) have expected count less than 5. The minimum expected count is
4.49.

V1 Residency * V8 Employment status

Crosstab
Count
V8 Employment status
1 Working

2 Retired

3 Unemployed

4 Housewife

5 Student

1 Maadi

207

17

7

136

35

2 Shagret Mariam

183

3

40

151

23

390

20

47

287

58

V1 Residency

Total

Crosstab
Count
Total

1 Maadi

402

2 Shagret Mariam

400

V1 Residency

Total

802

Chi-Square Tests
Value

df

Asymp. Sig. (2sided)

Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear Association
N of Valid Cases

37.709a

4

.000

41.171

4

.000

1.420

1

.233

802
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a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is
9.98.

V1 Residency * V10 Household monthly income
Crosstab
Count
V10 Household monthly income
1 Less than 1500
1 Maadi

2 1500 - 4000

3 4000 - 6000

4 6000 - 8000

0

0

4

16

11

243

130

13

11

243

134

29

V1 Residency
2 Shagret Mariam
Total

Crosstab
Count
V10 Household monthly income
5 8000 - 10000
1 Maadi

6 10000 - 12000

Total

7 More than 12000

67

165

150

402

0

0

0

397

67

165

150

799

V1 Residency
2 Shagret Mariam
Total

Chi-Square Tests
Value

df

Asymp. Sig. (2sided)

Pearson Chi-Square

754.786a

6

.000

Likelihood Ratio

1031.755

6

.000

686.188

1

.000

Linear-by-Linear Association
N of Valid Cases

799
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a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is
5.47.

V1 Residency * V16 Smoking
Crosstab
Count
V16 Smoking
0

Total

1 Yes

1 Maadi

264

138

402

2 Shagret Mariam

308

92

400

572

230

802

V1 Residency

Total

Chi-Square Tests
Value

df

Asymp. Sig. (2-

Exact Sig. (2-

Exact Sig. (1-

sided)

sided)

sided)

12.580a

1

.000

Continuity Correctionb

12.032

1

.001

Likelihood Ratio

12.645

1

.000

Pearson Chi-Square

Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases

.000
12.564

1

.000

802

a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 114.71.
b. Computed only for a 2x2 table

APPENDIX F
119

.000

T-test of Percentage for Significant Differences
T-Test
Group Statistics
V1 Residency

N

Mean

Std. Deviation

Std. Error Mean

1 Maadi

402

.82

.382

.019

2 Shagret Mariam

400

.66

.474

.024

1 Maadi

402

1.12

.329

.016

2 Shagret Mariam

400

1.08

.264

.013

1 Maadi

402

.13

.341

.017

2 Shagret Mariam

400

.08

.264

.013

1 Maadi

402

.51

.500

.025

2 Shagret Mariam

400

.13

.331

.017

V17 Antibiotics taken in last 6

1 Maadi

402

.24

.428

.021

month

2 Shagret Mariam

400

.18

.385

.019

V18 Antibiotics taken in last 6

1 Maadi

305

.67

.470

.027

month (kids/family)

2 Shagret Mariam

328

.62

.487

.027

V20 Did you self-medicate with

1 Maadi

302

.13

.336

.019

antibiotics

2 Shagret Mariam

274

.47

.500

.030

V24 Frequency of the dose as

1 Maadi

302

1.00

.000

.000

recommended

2 Shagret Mariam

274

.99

.120

.007

V25 Duration of antibiotics as

1 Maadi

302

.99

.099

.006

recommended

2 Shagret Mariam

274

.93

.255

.015

V26 Antibiotics treat viruses &

1 Maadi

389

.96

.193

.010

bacteria

2 Shagret Mariam

400

.84

.372

.019

V27 Going to another physician

1 Maadi

402

.03

.184

.009

for antibiotics

2 Shagret Mariam

399

.03

.157

.008

V28 Diarrheal meds in last 3

1 Maadi

402

.35

.478

.024

month

2 Shagret Mariam

400

.21

.406

.020

V5 Children

V11 Self-reported health

V12 Chronic Illness

V14 Medical Insurance
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V29 Constipation meds in last 3

1 Maadi

402

.19

.394

.020

month

2 Shagret Mariam

400

.03

.171

.009

1 Maadi

402

.11

.319

.016

2 Shagret Mariam

400

.07

.247

.012

1 Maadi

402

.34

.475

.024

2 Shagret Mariam

400

.23

.421

.021

1 Maadi

402

.7512

.43283

.02159

2 Shagret Mariam

400

.6850

.46510

.02325

V30 History of ulcer

V16 Smoking

totaluse

Independent Samples Test
Levene's Test for

t-test for Equality of Means

Equality of Variances
F

Sig.

t

df

Sig. (2tailed)

Mean

Std. Error

95%

Difference Difference Confidenc
e Interval
of the
Differenc
e
Lower

Equal variances

118.940

.000

5.375

800

.000

.163

.030

.104

5.372

763.5

.000

.163

.030

.104

assumed
V5 Children
Equal variances
not assumed
Equal variances
V11 Self-reported

assumed

health

Equal variances

66
16.166

.000

1.989

800

.047

.042

.021

.001

1.990

765.0

.047

.042

.021

.001

.006

.059

.022

.017

not assumed
V12 Chronic

Equal variances

Illness

assumed

14
31.337

.000
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2.753

800

Equal variances

2.755

.006

.059

.022

.017

800

.000

.387

.030

.329

12.93

696.0

.000

.387

.030

.329

5

62

2.132

800

.033

.061

.029

.005

2.132

791.7

.033

.061

.029

.005

not assumed
Equal variances
V14 Medical

assumed

Insurance

Equal variances

10
513.139

.000

Equal variances

12.92
2

not assumed

V17 Antibiotics

753.7

18.395

.000

assumed

taken in last 6
month

Equal variances
not assumed

V18 Antibiotics

Equal variances

taken in last 6

assumed

month

Equal variances

(kids/family)

not assumed
Equal variances

V20 Did you self-

15
8.636

.003

1.477

631

.140

.056

.038

-.019

1.479

630.1

.140

.056

.038

-.018

16
327.641

.000 -9.805

574

.000

-.345

.035

-.414

-9.626

470.6

.000

-.345

.036

-.416

assumed

medicate with
antibiotics

Equal variances
not assumed
Equal variances

V24 Frequency of

10
18.375

.000

2.112

574

.035

.015

.007

.001

2.011

273.0

.045

.015

.007

.000

assumed

the dose as
recommended

Equal variances
not assumed
Equal variances

V25 Duration of

00
61.792

.000

3.754

574

.000

.059

.016

.028

3.622

347.6

.000

.059

.016

.027

assumed

antibiotics as
recommended

Equal variances
not assumed
Equal variances

V26 Antibiotics

61
170.052

.000

5.974

787

.000

.126

.021

.085

6.022

602.8

.000

.126

.021

.085

assumed

treat viruses &
bacteria

Equal variances
not assumed
Equal variances

V27 Going to

98
2.631

.105

.810

799

.418

.010

.012

-.014

.810

781.2

.418

.010

.012

-.014

assumed

another physician
for antibiotics

Equal variances
not assumed

56
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Equal variances
V28 Diarrheal

83.773

.000

4.574

800

.000

.143

.031

.082

4.576

780.8

.000

.143

.031

.082

assumed

meds in last 3
month

Equal variances
not assumed
Equal variances

V29 Constipation

93
298.620

.000

7.526

800

.000

.162

.021

.119

7.539

547.1

.000

.162

.021

.119

assumed

meds in last 3
month

Equal variances
not assumed
Equal variances

V30 History of

assumed

ulcer

Equal variances

56
24.762

.000

2.454

800

.014

.049

.020

.010

2.456

754.5

.014

.049

.020

.010

not assumed
Equal variances

76
50.719

.000

3.570

800

.000

.113

.032

.051

3.572

789.5

.000

.113

.032

.051

assumed
V16 Smoking
Equal variances
not assumed
Equal variances

36
17.405

.000

2.088

800

.037

.06624

.03172

.00397

2.088

795.3

.037

.06624

.03173

.00396

assumed
totaluse
Equal variances
not assumed

14

Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of
the Difference
Upper
Equal variances assumed

.223

Equal variances not assumed

.223

Equal variances assumed

.083

Equal variances not assumed

.083

Equal variances assumed

.102

Equal variances not assumed

.102

V5 Children

V11 Self-reported health

V12 Chronic Illness
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Equal variances assumed

.446

Equal variances not assumed

.446

Equal variances assumed

.118

Equal variances not assumed

.118

V18 Antibiotics taken in last 6 month

Equal variances assumed

.131

(kids/family)

Equal variances not assumed

.131

V14 Medical Insurance

V17 Antibiotics taken in last 6 month

Equal variances assumed

-.276

Equal variances not assumed

-.275

V20 Did you self-medicate with antibiotics

Equal variances assumed

.028

Equal variances not assumed

.029

Equal variances assumed

.090

Equal variances not assumed

.092

Equal variances assumed

.168

Equal variances not assumed

.168

Equal variances assumed

.033

Equal variances not assumed

.033

Equal variances assumed

.205

Equal variances not assumed

.205

Equal variances assumed

.204

Equal variances not assumed

.204

Equal variances assumed

.089

Equal variances not assumed

.089

Equal variances assumed

.176

Equal variances not assumed

.176

V24 Frequency of the dose as recommended

V25 Duration of antibiotics as recommended

V26 Antibiotics treat viruses & bacteria

V27 Going to another physician for antibiotics

V28 Diarrheal meds in last 3 month

V29 Constipation meds in last 3 month

V30 History of ulcer

V16 Smoking

Equal variances assumed

.12852

Equal variances not assumed

.12853

totaluse
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APPENDIX G
Mann-Whitney U Test

1)

Mann-Whitney Test

Residency and Household income = significant difference
Ranks
V1 Residency

V10 Household monthly income

N

Mean Rank

Sum of Ranks

1 Maadi

402

588.62

236627.00

2 Shagret Mariam

397

209.00

82973.00

Total

799

Test Statisticsa
V10 Household
monthly income
Mann-Whitney U

3970.000

Wilcoxon W

82973.000

Z

-26.869

Asymp. Sig. (2-tailed)

.000

a. Grouping Variable: V1 Residency

2)

Mann-Whitney Test

Residency and self-reported health = significant difference
Ranks
V1 Residency

V11 Self-reported health

N

Mean Rank

Sum of Ranks

1 Maadi

402

409.42

164588.00

2 Shagret Mariam

400

393.54

157415.00

Total

802
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Test Statisticsa
V11 Self-reported
health
Mann-Whitney U

77215.000

Wilcoxon W

157415.000

Z

-1.914

Asymp. Sig. (2-tailed)

.056

a. Grouping Variable: V1 Residency

3)

Mann-Whitney Test

Residency and having chronic disease = significant difference
Ranks
V1 Residency

V12 Chronic Illness

N

Mean Rank

Sum of Ranks

1 Maadi

402

389.63

156633.00

2 Shagret Mariam

400

413.43

165370.00

Total

802

Test Statisticsa
V12 Chronic
Illness
Mann-Whitney U

75630.000

Wilcoxon W

156633.000

Z

-2.742

Asymp. Sig. (2-tailed)

.006

a. Grouping Variable: V1 Residency

4)

Mann-Whitney Test

Residency and having health insurance = significant difference
Ranks
V1 Residency

V14 Medical Insurance

N

Mean Rank

Sum of Ranks

1 Maadi

402

324.01

130253.00

2 Shagret Mariam

400

479.38

191750.00

Total

802
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Test Statisticsa
V14 Medical
Insurance
Mann-Whitney U

49250.000

Wilcoxon W

130253.000

Z

-11.761

Asymp. Sig. (2-tailed)

.000

a. Grouping Variable: V1 Residency

5)

Mann-Whitney Test

Residency and smoking = significant difference
Ranks
V1 Residency

V16 Smoking

N

Mean Rank

Sum of Ranks

1 Maadi

402

380.92

153131.00

2 Shagret Mariam

400

422.18

168872.00

Total

802

Test Statisticsa
V16 Smoking
Mann-Whitney U
Wilcoxon W

72128.000
153131.000

Z

-3.167

Asymp. Sig. (2-tailed)

.002

a. Grouping Variable: V1 Residency

6)

Mann-Whitney Test

Residency and Antibiotics Consumption in Adults
Ranks
V1 Residency

N

Mean Rank

Sum of Ranks

1 Maadi

402

389.24

156475.00

2 Shagret Mariam

400

413.82

165528.00

Total

802

V17 Antibiotics taken in last 6
month
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Test Statisticsa
V17 Antibiotics
taken in last 6
month
Mann-Whitney U

75472.000

Wilcoxon W

156475.000

Z

-2.127

Asymp. Sig. (2-tailed)

.033

a. Grouping Variable: V1 Residency

7)

Mann-Whitney Test

Residency and Antibiotics Consumption for children/care givers
Ranks
V1 Residency

N

Mean Rank

Sum of Ranks

1 Maadi

305

307.77

93870.00

2 Shagret Mariam

328

325.58

106791.00

Total

633

V18 Antibiotics taken in last 6
month (kids/family)

Test Statisticsa
V18 Antibiotics
taken in last 6
month (kids/family)
Mann-Whitney U

47205.000

Wilcoxon W

93870.000

Z

-1.475

Asymp. Sig. (2-tailed)

.140

a. Grouping Variable: V1 Residency

8)

Mann-Whitney Test

Residency and total use of antibiotics
Ranks
V1 Residency

N

Mean Rank

Sum of Ranks

1 Maadi

402

414.75

166729.00

2 Shagret Mariam

400

388.19

155274.00

totaluse
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Total

802

Test Statisticsa
totaluse
Mann-Whitney U

75074.000

Wilcoxon W

155274.000

Z

-2.084

Asymp. Sig. (2-tailed)

.037

a. Grouping Variable: V1 Residency

9)

Mann-Whitney Test

Residency and SMA
Ranks
V1 Residency

N

Mean Rank

Sum of Ranks

1 Maadi

302

335.81

101414.00

2 Shagret Mariam

274

236.36

64762.00

Total

576

V20 Did you self-medicate with
antibiotics
Test Statisticsa
V20 Did you selfmedicate with
antibiotics
Mann-Whitney U

27087.000

Wilcoxon W

64762.000

Z

-9.082

Asymp. Sig. (2-tailed)

.000

a. Grouping Variable: V1 Residency

10)

Mann-Whitney Test

Residency and Antibiotics treating viruses and bacteria
Ranks
V1 Residency

N

Mean Rank

Sum of Ranks

1 Maadi

389

369.28

143650.00

2 Shagret Mariam

400

420.01

168005.00

Total

789

V26 Antibiotics treat viruses &
bacteria
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Test Statisticsa
V26 Antibiotics
treat viruses &
bacteria
Mann-Whitney U

67795.000

Wilcoxon W

143650.000

Z

-5.943

Asymp. Sig. (2-tailed)

.000

a. Grouping Variable: V1 Residency

Table 7 showing the p values of Mann-Whitney U test on different variables.
Mann-Whitney Test for Significance
Variables

p Value

z score

Residency and Income

0.000

-26.869

Residency and Self-reported

0.056

-1.914

0.006

-2.742

0.000

-11.761

Residency and Smoking

0.002

-3.167

Residency and Antibiotics

0.033

-2.127

.140

-1.475

0.037

-2.084

Residency and SMA

0.000

-9.082

Residency and Antibiotics
treats viruses and bacteria

0.000

-5.943

health
Residency and Having a
Chronic Illness
Residency and Having Health
Insurance

Consumption in Adults
Residency and Antibiotics
Consumption for
children/care givers
Residency and Total
Consumption of Antibiotics
per Family
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3.9 Significance of Differences between the Two Areas

3.9.1 Residency and Income
A Mann-Whitney Test was done to assess if the difference between the levels of income
and the residency is significant or not. The test showed a significant difference in levels of
income between Maadi (n = 402) and Shagret Mariam (n = 400) with p value = 0.00.
Income was significantly higher in high-income areas compared to low-income areas.

3.9.2 Residency and Self-reported health
Another Mann-Whitney Test was done to assess the status of self-reported health and
residency and it showed a significant difference in the self-report health in the two areas;
Maadi and Shagret Mariam with p value = 0.05. In lower-income areas, “good” selfreported health status was reported more than in the high-income area.

3.9.3 Residency and Having a Chronic Illness
Identifying if there is a significant relationship between residents of Maadi and Shagret
Mariam in terms of having a chronic illness was illustrated by Mann-Whitney test. Test
results showed significant difference between the two areas in terms of having chronic
disease p value = 0.006. In the high-income area, double the number of participants had
chronic diseases compared to the low-income areas indicating that with higher
socioeconomic levels, people would report having chronic diseases

3.9.4 Residency and Having Health Insurance
A significant difference was indicated when running a Mann-Whitney Test between the
residency (area) and having a health insurance with a p value = 0.00. In the high-income
area, participants who had health insurance coverage was four times more than in the lowincome area.
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3.9.5 Residency and Smoking
Significant difference between smokers in Shagret Mariam and Maadi examined using
Mann-Whitney test which showed that higher number of smokers where found more in the
high-income area than in the lower p value = 0.002.

3.9.6 Residency and Antibiotics Consumption in Adults/ Study Participants
Mann-Whitney test showed a significant difference in the consumption of antibiotics by
adults between Maadi and Shagret Mariam with a p value = 0.033. Maadi residents (highincome area) consumed more antibiotics than in the lower-income area.

3.9.7 Residency and Antibiotics Consumption for children/care givers
hen testing antibiotic consumption but for children and care receivers, there was no
significant difference between the levels of consumption in Maadi and in Shagret Mariam
with a p value = 0.140. In both the high and low-income areas, consumption of antibiotics
by care receivers was not significantly different.

3.9.8 Residency and Total Consumption of Antibiotics per Family
Mann-Whitney test was conducted to assess the prevalence of antibiotic consumption
(total/per family) and the area of residency (socioeconomic level). A significant
relationship was observed with p value = 0.037. Higher rates of total antibiotics
consumptions were found in the high-income area compared to the low-income area.

3.9.10

Residency and SMA

Mann Whitney test between SMA and residency (socioeconomic level represented in the
area) revealed a significant difference between Maadi and Shagret Mariam and prevalence
of SMA with p value = 0.000. Prevalence of SMA was found to be significantly higher in
low-income areas more than in high-income areas.
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3.9.11

Residency and Antibiotics treats viruses and bacteria

Knowledge on antibiotics’ effectiveness in treating bacterial and viral infection was
assessed if significantly different in the two areas. Results showed a significant relationship
with p value = 0.000.

APPENDIX H
Maps of Maadi and Shagret Mariams
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Appendix I
Approval of IRB
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Appendix J
APDI index for Area Selection
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